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ABSTRACT
The Perceived Effectiveness of School-Based Accommodations for
Students with Systemic Lupus Erythematosus
by MaryAnn Seng

Pediatric patients with systemic lupus erythematosus battle a chronic, autoimmune illness
which can be life-threatening in cases of vital organ involvement. Disease activity and severity
is harsher during the developmental period of childhood and adolescence than during adulthood.
Lupus symptoms and medication side effects may cause patients to experience neurocognitive
and/or physical impairment. The cyclical nature of the illness consists of flare and remission
phases. The present study explored the topic of pediatric lupus in the school setting due to the
severe impact of the illness on youth. It examined the accommodations provided to students, as
well as the patients' preferred accommodations. Anonymous English and Spanish surveys were
placed in the waiting rooms of three lupus clinics in three different California counties. The
target population consisted of middle and high school students who have the diagnosis of lupus.
Surveys were completed by the students or by their parents/guardians. They were asked to list
the ideal educational accommodations that is needed to earn a high school diploma. They were
also asked about their present accommodations and services. A total of 39 surveys were
collected in approximately five months. Based on the grade point averages, all of the students in
the sample were passing their classes. The educational accommodation that was preferred most
often by the pediatric patients with lupus was the need for extended time to complete
assignments. It was the top choice among the presently given-accommodations list and the ideal
accommodations list.
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Chapter One: Introduction
The "Americans with Disability Act" and section 504 of the "American Rehabilitation
Act of 1973" are federal laws that have allowed the implementation of "reasonable
accommodations" within the workplace, as well as through 504 plans in the school environment.
Such laws have allowed individuals with disabilities to integrate into their communities and
participate in tasks and activities that are comparable to their typically developing peers.
Although the word "accommodation" is a commonly used term, the “Individuals with
Disabilities Education Act” (IDEA) does not carefully define that exact term in the law. The
present study will employ Harrison’s definition, since it is the result of a comprehensive
literature review: "Changes in practices that hold a student to the same standard as students
without disabilities (i.e. grade-level academic content standard) but provide a differential boost
(i.e. more benefit to those with a disability than those without) to mediate the impact of the
disability on access to the general education curriculum (i.e. level the playing field)" (Harrison,
2013, p. 556).
Students with medical needs are entitled to accommodations in the classroom, but data
are lacking as to how many pediatric patients with systemic lupus erythematosus (abbreviated to
"lupus") are actually provided with that support. Old data from a study by Lahita (1988) showed
that 12.5% of lupus patients were diagnosed with some type of learning disorder, such as
dyslexia. Certain medical conditions, like lupus, may not present itself as impaired as other
conditions, which may result in patients being overlooked by educators. Families may not know
their rights, so students are left without any academic support.
The topic of systemic lupus erythematosus (SLE) and the educational environment is
important due to the findings of one study which links the two topics involving adult patients
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with autoimmune conditions. This study sought to examine any association between mortality
from autoimmune illnesses and school teaching. Walsh and DeChello (2001) calculated the
proportional mortality ratios from the death certificates of teachers during the years of 19851995. The results showed excess mortality among elementary and secondary school teachers
from autoimmune illnesses. If the health of teachers with lupus is at risk in the school setting,
pediatric patients who are exposed to the same environmental setting likely are at equal, or
possibly even more, risk with their immunosuppressed conditions. Polychlorinated biphenyls
(PCB's) remain in many classrooms across America even though such chemicals were banned
four decades ago (Webber & Irvine, 2019). Older schools are at more risk of having the illegal
substances in their "caulk, ceiling tiles, and paint". Webber and Irvine (2019) stated that the
levels of the banned chemicals have been shown to contain much higher levels than what is
allowed by the Environment Protection Agency (EPA).
A Harvard health professor, Dr. Robert Herrick, studied the specific use of PCB's in
school buildings and reported that PCB's were commonly used as a plasticizer in the caulk which
were used in school buildings built before 1980. The EPA later learned that such materials can
be inhaled or ingested via dust or air. Because of that, other surfaces can absorb the chemicals,
which would result in the continual existence of the PCB's. Researchers have established that
PCB’s are highly dangerous to those with lupus (Mak & Tay, 2014, Tsai et al., 2007).
It is that medical risk in the school environment that inspired this researcher to examine
the best educational accommodations for secondary students with systemic lupus erythematosus.
By understanding what types of support pediatric patients currently have and knowing the
supports that they would like to have, steps can be taken to bridge any disparities for the sake of
patients’ medical, psychological, and educational functioning.
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Statement of the Problem
Systemic Lupus Erythematosus is one of the most overlooked diseases as it slowly robs
pediatric patients of their lives and/or their quality of life. Lupus is usually most severe during
the adolescent years, so extra precaution must be taken during that developmental period in order
to preserve patients' vital organs. Despite the young patients’ use of powerful
immunosuppressants, school attendance remains a legal mandate. Receiving services through
programs such as the "Home and Hospital Instruction Program" (CA Ed Code 48206.3) is a
possibility for a small percentage of severe cases, but the majority of chronically ill pediatric
patients must continue to attend school on a daily basis.
School can then become a possible risk factor due to the exposure of various bacteria and
viruses in the educational environment. The stress that is often associated with school can also
increase the psychological risk, especially to chronically ill patients who struggle to keep up with
academic demands. That stress can make patients more susceptible to increased disease activity
due to the psychoneuroimmunological connection. The problem to be addressed in this study
encompasses possible ways to protect pediatric patients with lupus from increased harm to their
health status.
Purpose Statement
The purpose of the present study was to examine the present and preferred
accommodations for students with systemic lupus erythematosus. The findings from this study
may allow physicians and educators to make research-based recommendations for the benefit of
pediatric patients' functioning in the school environment. The recommendations can then be
implemented in students’ 504 Plans and Individualized Education Plans (IEP's). The present
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study seeks to discover which educational accommodations are perceived by adolescents to be
most beneficial for their academic achievement and physical well-being at school.p
This exploratory effort will contribute to the present literature by adding to our
understanding of the educational needs of SLE from the viewpoints of pediatric patients
themselves. In general, pediatric quality-of-life issues among those with systemic lupus
erythematosus have not been examined as closely as quality-of-life issues in adults. Now that
physicians and scientists have produced research-driven evidence on the severity and morbidity
of pediatric lupus, it is crucial to seek ways to ease the condition beyond medical treatment
alone.
Research Questions
Research Question 1a: What are the educational accommodations that participants are presently
receiving? The participants were asked to rank their current accommodations (which have
already been provided by their schools) according to their helpfulness toward earning a high
school diploma.
Research Question 1b: What are the participants’ favorite accommodations in rank order out of
the presently-received accommodations? The participants were asked to rank their current
accommodations (which have already been provided by their schools) according to their
helpfulness toward earning a high school diploma.
Research Question 2: What are the participants’ preferred or ideal accommodations in rank
order in terms of helpfulness toward earning a high school diploma?
Research Question 3: Is there any relationship between participants' grade point average and
their total number of medications?
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Research Question 4: What is the percentage of participants who currently have a 504 Plan or an
Individualized Education Program (IEP) in place?
Research Question 5: How similar or dissimilar are the rank-ordered lists of given
accommodations and the ideal accommodations?
Significance of the Study
The present study is significant due to the fact that pediatric patients with systemic lupus
erythematosus have a life-threatening illness, but it is currently not known what type of
assistance would best support these pediatric patients in the school setting. The disease activity
of lupus is most severe during the adolescent years, so every precautionary effort should be
attempted during this time period for the sake of survival. Because middle and high school are
challenging enough in various psychosocial and academic ways, adequate support has the
potential to mitigate patients' stress level, thereby easing disease activity.
By having patients self-report their preferences through a survey, determining the best
accommodations can come directly from the patients' own experience. Compiling their
preferences would allow the medical and educational community to gain a greater understanding
of which accommodations may be most beneficial for implementation in the school setting.
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Chapter Two: Literature Review
Introduction to Systemic Lupus Erythematosus
The medical diagnosis of “systemic lupus erythematosus” was coined from a
combination of Latin and Greek terminology (Boston Children's Hospital, 2019). "Lupus" comes
from the Latin translation of the word “wolf,” while "erythema" is the Greek word for "red."
Rogerius, a 13th century physician/researcher, selected the name based on observations of
reddish facial lesions on patients' noses and cheeks (Lupus Foundation, 2020). The lesions
reminded him of bite marks from a wolf. In modern times, that malar rash is described by
physicians as being a "butterfly rash", due to its butterfly-shaped presence on the nose and
cheeks (Coughlin, 2019). Approximately 30% of patients with systemic lupus erythematosus
have the distinctive, butterfly-shaped rash (Coughlin, 2019). Some patients may also exhibit
discoid rashes, which are irregular red rashes that may be found on the chest or neck (Kidshealth,
2019).
The word "systemic" is included in the diagnosis, because the illness may impact various
organs within the human body (LFA, 2020). It has the potential to affect any organ system within
the human body (Lindsey, 2020). Personal variation can occur within each affected organ, as
well as variation in the severity of the autoimmune response. Such a wide variety of
manifestations can make it difficult for physicians to produce an accurate diagnosis, which is
why a correct diagnosis of lupus can take almost six years, on average, for adults (LFA, 2016).
Approximately 63% of patients were given incorrect, initial diagnoses prior to the correct lupus
diagnosis (Maloney, 2015).
Systemic lupus erythematosus (known as SLE or simply "lupus") is classified as an
autoimmune illness, which is under the umbrella of rheumatological conditions. On the
6

“MedicineNet” website, "autoimmunity" is medically defined as a "misdirected immune
response that occurs when the immune system goes awry and attacks the body itself" (Shiel,
2018). The immune system attacks its own healthy cells, tissues, and organs within the body,
instead of guarding them from disease.
The Lupus Foundation of America (2020) reported that the cause and cure for the
autoimmune condition remains unknown. The most common hypotheses for the lupus phenotype
include issues involving hormones, the environment, and genetics (LFA, 2020). A genetic
predisposition to lupus may be activated by something outside of the body. Both internal and
external factors interplay in a manner that has yet to be understood. For example, Temple
University scientists found that bacterial communities and an abnormal protein can contribute to
the exacerbation of lupus (Mayo Clinic, 2018).
Lupus is a life-threatening condition that is marked by cyclical, unpredictable periods of
remission and flare-ups, and medical risk is greatest during the flares. Each period of remission
or flare may vary in terms of the symptoms, timeframe, and severity. The greatest danger of
lupus occurs when one or more of the patient’s vital organs are under siege by the immune
system. Medical complications may occur during this process of treating lupus and treating the
affected organ. Consequently, other medical specialists are often needed for collaboration during
flare periods.
Kidneys are most commonly attacked in lupus (lupus nephritis), and it is no longer
uncommon to require kidney transplants to replace the damaged ones. Kidney complications
occur in approximately 60% of lupus patients (Metelski & Rovin, 2017). Some hospitals
combine a lupus clinic with a nephrology clinic, so that kidney complications can be caught and
monitored early in the disease process.
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Factors which can contribute to the increased possibility of entering a flare state involve
having too much physical stress, emotional stress, or overexposure to the sun (Iliades, 2015).
Thus, lifestyle changes are usually necessary in order to avoid a lupus flare. Some flares manage
to occur without any warning symptoms (LFA, 2020). Consequently, the unpredictable nature of
the illness requires close monitoring by the treatment team.
Types of Lupus
The American College of Rheumatology has distinguished four different types of lupus.
They include: cutaneous/discoid lupus erythematosus, drug-induced lupus erythematosus,
neonatal lupus, and systemic lupus erythematosus. Cutaneous lupus is also known as "discoid
lupus erythematosus", and it produces skin discoloration and atypical skin issues as a result of
the immune system attacking the skin (Eastham & Vleugels, 2014).
Drug-induced lupus is a condition which matches its name. Lupus can be induced by
certain medications, but the effects are temporary. Those medications which can initiate lupuslike symptoms are starting to be shunned as other medicinal alternatives become available.
Young patients may experience joint pain, severe fatigue, and fever. However, this form of lupus
often does not affect the vital organs, which the traditional form of lupus can do. Symptoms of
drug-induced lupus will usually disappear within a few weeks after the triggering medication is
discontinued (Boston Children’s Hospital, 2019). Some anticonvulsants may have this effect of
mimicking lupus symptoms.
Neonatal lupus is a form of lupus that can affect the babies of women with certain
antibodies. Approximately 40% of the mothers who have children with neonatal lupus
erythematosus, have lupus themselves (Johns Hopkins Medicine, 2020). With neonatal lupus, the
auto-antibodies impact the baby through the placenta, and the impact usually ends within the first
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several months of the infant's life. The auto-antibodies eventually disappear from the infant's
immune system. The condition is dangerous due to the possibility of leaving permanent cardiac
damage in the infant (Johns Hopkins Medicine, 2020).
Because systemic lupus erythematosus is the most common and most dangerous form of
the illness, the present study will focus on the systemic phenotype rather than the other types of
lupus (Lindsey, 2018). Approximately 70% of lupus patients have the systemic type of lupus,
which carries the greatest risk to the organs and to the lives of affected pediatric patients.
Incidence and Prevalence of Systemic Lupus Erythematosus
In order to fully understand the proportional magnitude of autoimmunity, current
statistics may shed light on its prevalence within the United States. The National Institutes of
Health estimates that 23.5 million individuals have some form of an autoimmune disease
(AARDA, 2018). For the sake of comparison, heart disease affects 22 million individuals, and
cancer impacts 9 million patients (AARDA, 2018). The Lupus Foundation estimates that 16,000
new pediatric and adult cases are diagnosed each year (LFA, 2016).
The Center for Disease Control (CDC) acknowledges that autoimmune illnesses are "on
the rise", but no valid reasons for this phenomenon could be offered, because they remain
unknown (Rattue, 2012). Yen et al. (2018) found that SLE was the leading “chronic
inflammatory disease, ranking higher than diabetes mellitus, human immune deficiency virus
disease, chronic lower respiratory disease, nephritis, pneumonitis, and liver diseases,” in young
women who are between 15 and 24 years of age.
The Lupus Foundation of America estimates that approximately 1.5 million Americans
and 5 million individuals worldwide have systemic lupus erythematosus. The highest incidence
of lupus is in North America, which may possibly be due to the accuracy of diagnosis rather than
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the true prevalence of the illness (Rees, 2017). The lowest incidence of lupus was found in
Ukraine, Africa, and northern Australia. Lupus also appears to be more common in urban areas
than in rural areas (Schur & Hahn, 2020).
The link of lupus with urban environments was found in a study conducted in Brazil.
Researchers discovered that air pollution was "strongly associated" with pediatric lupus activity
(Ammam, 2016). The study prompted Dr. Maria Fernanda Goulart, Department of pediatric
Rheumatology at the University of Sao Paulo to state in a news release: "Our findings have
shown that air pollution doesn't just increase the incidence and prevalence of chronic lung
disease and acute respiratory infections. It is also an important contributory factor in childhood
rheumatic diseases, such as lupus" (EULAR, 2016). She also stated that "with air pollution
increasing in many major cities, pediatric rheumatologists can expect to see a resultant impact on
the disease activity of their lupus patients" (EULAR, 2016).
As for the statistics among patients who are under the age of 18, the Arthritis Foundation
estimates that approximately 25,000 children and adolescents have lupus or a related disorder
(Children’s Hospital of Philadelphia, 2019). Another estimate proposed that 30,000 children and
adolescents are affected (Onel, 2018). Childhood-onset lupus is estimated to equal approximately
15 to 20% of all lupus patients (Nationwide Children's Hospital, 2017).
As for the incidence of lupus among children under 18 years of age, it ranges from .36 to
1 per 100,000 children (Nabors et al., 2015). The prevalence rates of pediatric SLE is 4 to 250
cases per 100,000 individuals. One statistic showed that African-American children comprised
60% of all SLE patients under the age of 20 years old. The high prevalence of lupus among
African-American children matches the prevalence among the adult lupus population (Iliades,
2009).
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Diagnostic Criteria of Pediatric Systemic Lupus Erythematosus
The criteria for the diagnosis of lupus have been revised a few times throughout history
as we gain a greater understanding of the disease. Lupus is a very challenging illness to diagnose,
even among the most skilled of physicians. The reason for the difficulty is due to its mimicry of
other illnesses (New York State Department of Health, 2015). The symptoms of lupus can often
be subtle and easily overlooked by general practitioners. Lupus often mimics other conditions,
which is why the Lupus Foundation calls the illness "the great imitator" (LFA, 2016). For
example, the butterfly rash on lupus faces may not be dramatically visible. The time that is lost
during the search for a diagnosis may further impact affected organ(s), which impacts the
patient’s prognosis. Rekvig and Van der Vlag (2014) wrote that questions outnumber answers
regarding the etiology, diagnosis, and treatment of lupus. Consequently, subtle features and
symptoms may not be easily recognized.
The American College of Rheumatology established 11 specific criteria to guide
physicians when considering a lupus diagnosis (Paz, 2017). Due to the variability of organ
involvement and wide-ranging spectrum nature of the illness, a patient is not required to exhibit
each of these symptoms. The American College of Rheumatology and the Lupus Research
Alliance reported that children must have 4 of the 11 criteria before a diagnosis can be made.
The eleven specific criteria include:
1.

Skin rash – raised red patches or bumpy skin

2.

Photosensitivity – sun light can exacerbate the illness, causing increased disease
activity

3.

Mouth or nose ulcers – usually observable but painless

4.

Nonerosive arthritis – inflammation or pain in two or more joints.
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5.

Cardio-pulmonary involvement – inflammation of the heart lining and/or lungs

6.

Neurologic disorder – seizures and/or psychosis

7.

Kidney disorder – increased protein in urine sample or clumps of red cells

8.

Blood disorder – anemia (inadequate hemoglobin) caused by damaged red cells,
low white cells or low platelet count

9.

Immunological disorder – when the immune system attacks healthy cells,
autoimmune activity

10.

Antinuclear antibodies (ANA) – positive blood test not induced by drugs or other
chemicals

11.

Malar rash – a rash across cheeks and nose which resembles a butterfly

Gender and Racial Differences
Gender is a significant factor in the incidence and prevalence rates of lupus, because
lupus strikes females 8 to 15 times more than males (Murphy & Isenberg, 2013). The women
who are affected are usually within their child-bearing years, between the ages of 12 and 44
when they are diagnosed. Interestingly, during childhood, the ratio of females to males are not as
disproportional as during adulthood (Lo, 2018). Because of that fact, hormones are hypothesized
to play a role in the progression of the disorder.
Iliades (2009) described a pattern of ratios through a longitudinal lens by stating that
adult females outnumber adult male patients by 10:1. Among pediatric patients, females
outnumber male patients by 4:1. Males appear to be affected more during their childhood years
than during the adult years (Iliades, 2009). According to other statistics, the female to male ratio
has been estimated to be 4:1 before puberty and after menopause. The female to male ratio can
rise to 8:1 during the child-bearing period between menarche and menopause (Klein-Gitelman,
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2019). Such findings are the reason why researchers are examining hormonal influences in the
activation of the disease. It is not entirely known how the effects of puberty impact
autoimmunity and its pathophysiology (Ardoin & Schanberg, 2012).
In terms of race, lupus tends to strike minorities at a significantly higher rate than those
of Caucasian/European descent (Jewitt-Tenant, 2017). The prevalence of lupus in AfricanAmerican, Hispanic, and Asian women are all significantly higher than Caucasian women. As
for Native Americans, they are often diagnosed with lupus at a younger age and present with
more severe symptoms than other ethnic groups (Mumal, 2018).
Among pediatric patients with lupus, Hiraki et al. (2009) reported that 60% of the 265
patients in their study cohort were non-Caucasian. Non-Caucasian patients, especially those who
are African-American, were younger at diagnosis than Caucasian patients (12.6 years vs 14.6
years, p=0.007). Non-Caucasian patients were also more likely to have lupus nephritis (62% vs
45% p=0.01) (Hiraki et al., 2009). Mina and Brunner (2010) also reported "large variations"
involving lupus nephritis among the different races. It is unknown why minority patients’
kidneys may be more affected.
Morbidity and Mortality
Although lupus is viewed as a chronic illness, death remains a possibility, and it is highly
dependent on disease activity. UCLA researchers analyzed mortality statistics from the Centers
for Disease Control and Prevention from 1968 to 2013 and compared them with data from the
U.S. Census Bureau. A comparison of the data showed that the lupus mortality rate did not
decline as much as it did for the overall population (Yen et al., 2017). Increased rates for lupus
patients were reported during the 1970’s and 1990’s, but mortality decreased overall since 1968,
even among African-American patients (Yen et al., 2017).
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Medical advances have extended the lives of patients with lupus, but childhood-onset
lupus tends to have higher mortality rates (Walsh, 2010). Because the disease appears to be more
active during this period, the overactivity can lead to organ damage which can lead to death.
Rubinstein et al. (2015) noted that renal failure is a leading contributor to morbidity, but
neuropsychiatric issues are an equally, if not more, significant contributor to morbidity. Survival
for pediatric patients with lupus nephritis now exceeds 90% (Wenderfer et al. 2016).
Cardiovascular disease and infections also contribute to premature death (John Hopkins, 2019).
A recent study indicated that childhood-onset lupus had "an over 4-fold higher rate of
pericarditis/myocarditis” compared to adult-onset SLE" (Chang et al., 2018, p.2151). The
American College of Rheumatology questioned if death certificates underestimated the mortality
rate of “rare diseases” in Sweden (Falasinnu, 2017). Because the cause of death may be
attributed to organ complication(s) instead of the root illness of lupus, the death certificate may
not state lupus as the primary cause of death. For example, "kidney failure" may be listed on the
death certificate rather than the cause of the kidney failure, namely lupus nephritis. Thus, the
statistics regarding the number of deaths may be skewed. UCLA researchers confirmed this
hypothesis in America when they found that lupus is often not included on death certificates.
Consequently, the lupus mortality rates may not be accurate (Franki, 2018).
Hollander et al. (2013) reported that increased mortality is associated with pediatric lupus
rather than with adult-onset lupus, and adults with childhood-onset lupus carry a greater
mortality risk than those with adult-onset lupus (Walsh, 2010). More disease damage has also
been documented among young patients. Cumulative organ damage was observed in
approximately 50% to 60% of pediatric patients, which contributes to the increased impact of the
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disease on the body (Ravelli, 2005). It is known that approximately 10% of children will not
survive ten years after their lupus diagnosis (Ravelli, 2005).
Lupus was described as "quietly killing young women" after it became the 10th leading
cause of death among young women between 15 and 24 years of age (Franki, 2018). It was also
the 14th leading cause of death for women who are between 25 and 44 years of age (Franki,
2018). The racial disparities are also evident through the higher mortality rates among minority
women in general (Alarcon et al, 2006).
The 5-year and 10-year survival rates are comparable between pediatric and adult onset
lupus. Tektonidou et al. (2017) reported that the survival rate among children during the span of
years between 2008 and 2016 is statistically significant when comparing those from high-income
and low-income countries, and that 5-year and 10-year survival rates were lower among pediatric
patients than adult patients in low to middle-income countries. Pediatric patients from middle to
low-income countries had a lower survival rate than adults from those same countries
(Tektonidou et al., 2017). Similar socioeconomic differences exist in both adult and pediatric
patients, based on studies from 1950 to 2016 (Tektonidou et al, 2017). High-income countries
produced 5-year survival rates which exceed 95% in both adult and pediatric patients.
Despite steady improvement, lupus survival appears to have peaked during the mid-1990s
(Tekonidou, 2017). These findings stem from 125 studies on adult patients and 51 studies on
pediatric patients. During the time frame between 2008 and 2016, the 5-year, 10-year, and 15year lupus survival rates appears to have gradually decreased. The same pattern was found for
pediatric patients during those same years. That pattern remained consistent regardless of the
income of the patient. Brunner and Gitelman (2009) acknowledged that there are access issues
for certain individuals due to limited coverage by insurance companies. That fact may explain
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the difference in mortality rates, when one compares the coverage of the various ethnic groups of
patients.
A large, international study on lupus revealed that deaths during the years of 1958-2001
were more likely to occur if certain complications are involved (CDC, 2018). They include:
active disease, organ failure, infection, or cardiovascular disease relating to atherosclerosis. In
addition, lupus-related deaths were more frequent among young females who have had the
illness for a relatively short amount of time. In 2002, the CDC issued a report stating that lupus
deaths increased above the preceding 20-year period, despite some limited medical advances
(CDC, 2018).
The increase was most evident among African-American women between the ages of 45
and 64 years. The fatality rate of African-American lupus patients is usually three times higher
than Caucasians (CDC, 2002). According to data gathered in the state of Georgia from 20022016, the incident mean age at death for African-Americans was 51.8 years while Caucasians
equaled 64.4 years (Lim et al., 2019). Neurological complications, hemorrhage, and stroke tend
to occur more frequently among African-American patients. However, kidney failure and cardiac
issues are more common among Hispanic women (CDC, 2002). African-Americans had a
significantly persistent higher rate of mortality starting from their initial diagnosis, and gender
did not reveal any significant differences (Lim et al., 2019).
In an attempt to address and explain the racial disparities, numerous researchers united in
1993 to examine the nature and nurture aspects of lupus. Their efforts came to be known as the
LUMINA ("Lupus in Minorities") study (Jewitt-Tenant, 2017). The most crucial findings from
ten years of data indicated that poverty and lack of access to healthcare are key contributors to
the increased likelihood of mortality among minorities.
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Although the findings are relevant to the understanding of lupus in adults, their value and
application can be extended to pediatric rheumatology. By knowing the specific groups who are
at highest risk for mortality from lupus, research can focus on the corresponding pediatric
population for the sake of early identification and preventive treatment.
Childhood-Onset Lupus
It has been documented that childhood-onset lupus is associated with more severe disease
activity and impairment than adult-onset lupus (Tunnicliffe, 2015). Young patients with lupus
experience more cardiovascular, renal, and neuropsychiatric issues than adult patients
(Tunnicliffe, 2015). The treatment options are very similar to adult lupus patients, so young
bodies must be treated with powerful immunosuppressant medications, which increases their risk
of additional medical complications. When the immune system attacks the organs, organ damage
and comorbid complications can occur. The disease activity, the comorbid complications, and
the adverse side effects from medications combine to impede the young patient from living a
"normal childhood".
Approximately 10 to 20% of patients experience the onset of systemic lupus
erythematosus during adolescence or childhood. From a biomedical perspective, early
presentation of the disease symptoms may also indicate a strong genetic contribution (Lo, 2018).
In 2013, the first international consensus (involving the United States, India, Brazil) on
indicators of pediatric systemic lupus erythematosus was reached (Mina et al., 2015). As
expected, there were numerous similarities with adult markers of systemic lupus erythematosus.
However, specific patterns of disease activity were more apparent among childhood-onset lupus
than adult-onset lupus, and they were incorporated into the diagnostic profile (Mina et al., 2015).
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Hedrich et al. (2017) found that the inflammatory symptoms of systemic lupus erythematosus
manifests in 10-20% of patients under 16 years of age.
The most frequent symptoms that pediatric lupus patients display are fever, fatigue, and
weight loss. The most common organ-related impact that the disease can have on the body
includes distress on the skin, kidneys, and musculoskeletal system (Thakral & Klein-Gitelman,
2016). The age of lupus onset is important in determining the type of challenges that may be
present in the future. After examining the various quality indicators for pediatric lupus care, it
was found that other countries, outside of the United States of America, could not meet
"evidence-based minimum standards of medical care" (Thakral & Klein-Gitelman, 2016). The
lack of care contributes to further complications and increased morbidity.
The prognosis for pediatric patients depends on the level of individual organ
involvement. Special attention must be given to pediatric lupus patients with the following
disease factors (Thakral & Klein-Gitelman, 2016):
a. High dose glucocorticoid therapy (man-made versions of naturally occurring steroids
within the body) during the initial diagnosis
b. Antibody profile testing
c. Adequate opthalmological examinations (since a key lupus medication,
hydroxychloroquine, may damage the retina)
d. Symptoms of lupus nephritis
e. Pharmacological safety
Pediatric Systemic Lupus Erythematosus
Due to the wide spectrum of symptoms, no single test has been identified to pinpoint a
diagnosis of lupus. Physicians base their diagnosis on the child's medical history, current
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presenting symptoms, a thorough physical examination, and various diagnostic tests and/or
scans. Examples of the various tests include blood tests to examine specific antibodies,
urinalyses to investigate kidney functioning, and x-rays to assess internal organs and bones.
As for the specific tests that are closely scrutinized on blood tests, rheumatologists
usually examine several key factors. One of them is the erythrocyte sedimentation rate,
commonly known as the ESR or "sed rate". That test measures the rate at which red blood cells
fall to the bottom of a test tube. When cells are inflamed and swelling, the red blood cells
become heavier than normal, which allow them to fall faster to the bottom of a test tube.
The C-reactive protein is another commonly examined factor because it is indicative of
the amount of inflammation in one's body. Inflammation is a key factor in autoimmune disease
progression. Protein complements are also important when assessing disease activity. They are a
group of proteins within the blood that assist with the destruction of foreign substances (Janeway
et al., 2001). The system of complements helps to defend the body from infection (Janeway et
al., 2001).
Treatment for Lupus
Even though there is no cure for lupus, there are certain treatments that can alleviate
some of the symptoms. The factors that determine the proposed treatment involve the patient's
age, health history, tolerance for certain medications and therapies, affected organs, and the
extent of the autoimmune activity.
It is a challenge to treat an illness whose etiology and biological processes are not fully
comprehended. Treatment options are very limited for both adult and pediatric patients. The
choice of treatment depends on the presenting symptoms and severity of disease activity.

19

Additional medications may be prescribed as other complications arise. The list of possible ways
to treat lupus include:
- Non steroidal anti-inflammatory drugs (NSAID)
- Hydroxychloroquine
- Corticosteroids (e.g. prednisone, prednisolone, Medrol)
- Other types of immunosuppressive medications (ex. cyclophosphamide, methotrexate)
- Monoclonal antibodies
- Consistent use of sunscreen and avoidance of the sun
- Adequate rest and stress reduction strategies
- Well-balanced (sometimes low sodium) diet
- Other medications for specific infections or organ complications.
The pharmaceutical treatment options for lupus all have potentially serious side effects.
Corticosteroids were first introduced by Hench, and the Merck company began to mass produce
this key lupus medication in 1948. Corticosteroids include medications such as prednisone,
prednisolone, and methylprednisolone. This family of medications has severe side effects, which
include a significant swelling of the face (also known as “moon face”), hypertension,
osteoporosis, weight gain, increased vulnerability to infection, easy bruising, and muscle
weakness. Corticosteroids also impact memory and mood, and may contribute to changes in the
hippocampal structure (Brown et al., 2004). Despite the serious side effects, corticosteroids are
effective for calming inflammation and alleviating lupus-related symptoms (LFA, 2020).
Corticosteroids have been described as being "a metaphorical double-edged sword" due to its
healing properties and adverse side effects (Drosdowicz & Bostwick, 2014).
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In addition to corticosteroids, treatment options include anti-malarial medications, such
as Plaquenil (hydroxychloroquine), and cytotoxic/immunosuppressive agents, such as Cytoxan
(Hochberg & Alarcon, 2017). Chemotherapy is administered in life-threatening cases of lupus.
The latest treatment option among adult patients involves the use of a hormone called
dehydroepiandrosterone (DHEA), but its benefits are debatable, according to researchers
(Sawalha, 2008). This hormone was found to increase when patients are in a mode of relaxation,
as opposed to the release of cortisol when patients are in a stressful state of mind. In 2011, the
Federal Drug Administration approved a medication for lupus called belimumab (Benlysta). This
was the first medication to be approved for lupus in over 50 years (CDC, 2018).
Medication compliance is a major concern among lupus patients. A systematic review of
11 studies involving self-reported information revealed that over half of lupus patients are not
taking their medications as directed by their physicians. Antimalarial medications had one of the
worst compliance rates among lupus patients (Pharmaceutical Technology, 2017). These
medications offer long-term benefits without marring the patient’s appearance or functioning, as
corticosteroids usually do. The primary adverse side effect of the medication is that a very small
percentage of patients may experience retinal toxicity (Pharmaceutical Technology, 2017). That
is why regular opthalmological monitoring is required for those who are on a daily regimen
involving hydroxychloroquine, the most commonly prescribed anti-malarial medication.
Consequential Side Effects and Complications from Treatment
Dr. Emily von Scheven (2020) reported that better treatments are being developed for
pediatric lupus cases, but physicians are finding that there are secondary complications. These
complications can sometimes be as serious as lupus itself. That is why this chronic illness
requires multi-faceted, precautionary monitoring. For example, hospitalized infections were
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found to be common among children with lupus (Hiraki, 2017). These infections can be
bacterial, viral, or fungal. Children who ingest corticosteroids have higher infection rates than
those who do not, because they suppress the immune system (Hiraki, 2017). Further, because
children require vaccinations, children with pediatric lupus should not receive immunizations
with live viruses. These types of live vaccinations include the chicken pox vaccine, measles,
mumps, rubella, and oral polio vaccines.
Corticosteroids may also impede children’s height. A study conducted by HeshinBekenstein (2019) found that pediatric lupus patients were 2.4 centimeters shorter on average
than their peers. The reason for the disparity in height involves the onset of lupus during puberty,
which coincides with the period when children grow the most. There are numerous possibilities
to explain the height differences, with one of them being side effects from the corticosteroids.
Bandeira et al. (2006) found that discontinuing corticosteroid treatment resulted in some “catch
up growth.”
Pain Management
Pain management may require some psychological intervention, in addition to medical
intervention (Nabors et al., 2015). Although there are limited studies with children, physicians
generally endorse the use of pain-alleviating strategies for adults to be used with children. Prior
to the implementation of pain interventions for children, it is recommended that a thorough
explanation be provided to them for their understanding. Three strategies were mentioned by
Nabors et al. (2015). They include cognitive-behavioral therapy, the elimination of negative
thoughts, and relaxation techniques.
Hui et al. (2017) found that cognitive-behavioral therapy can be successful at alleviating
pain and depression in adults. Neurocognitive dysfunction can change or be persistent over time.
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Risk factors are not completely understood, but a longitudinal study of 123 multi-ethnic adults
with SLE, known as the "Salud" study, revealed that a higher level of depression is associated
with neural cognitive dysfunction (McLaurin et al., 2005). The elimination of negative thoughts
can be achieved through several methods, including slower breaths or deep breathing, muscle
relaxation, and thought replacement strategies. With these types of strategies, adults were found
to experience decreased stress, depression, and overall pain. Similar relief can be expected for
children as a means of alleviating their pain and helping them function in school (Nabors et al.,
2015).
Prognosis for Pediatric Patients with Systemic Lupus Erythematosus
Due to the fluctuating spectrum nature of disease activity, absolute certainty from
rheumatologists regarding each patient’s prognosis is not possible. The prognoses of pediatric
patients with systemic lupus erythematosus is highly dependent on the level and the type of
organ involvement that is impacted (LFA, 2013). On July 1st, 2019, the Childhood Arthritis and
Rheumatology Research Alliance (CARRA) and the Lupus Foundation of America prioritized
lupus nephritis and neuropsychiatric disease as the two most "urgent, unmet needs in childhood
onset lupus."
Key variables in SLE patient outcomes include "hospitalizations, disease activity, disease
damage, mortality and quality of life" (Lawson & Yazdany, 2012, p. 96). The LUMINA study
concluded that organ damage and poverty were significant predictors of mortality among adult
patients (Bertoli et al., 2008). The organ that is involved will be a significant factor in the level
of disease severity, which would then help predict morbidity or mortality (Lim et al., 2014). In
general, lupus is a chronic illness where the majority of patients do survive if proper health
maintenance measures, such as medication compliance and avoidance of ultraviolet light, are
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followed consistently. With the longer lifespan than in the past, there are more pediatric patients
living with more disease activity and accrued damage within their bodies (Aggarwal &
Srivastava, 2015).
Cutaneous Problems
There are three types of cutaneous, or skin, problems involving pediatric systemic lupus
erythematosus. They include acute, subacute, and chronic cutaneous disorder (Eastham &
Vleugels, 2014). Acute cutaneous lupus consists of redness across the nose and cheeks, which is
the “butterfly rash.” Subacute cutaneous lupus involves a red and scaly rash across sun-exposed
areas of the body. Chronic cutaneous lupus consists of red and purple rashes and scars, and it
may also include patches of hair loss and scarring in the bowl of the ear.
Sunlight exacerbates all three types of cutaneous lupus. Consequently, cutaneous issues
present as an issue that must be addressed in the educational plan of the child, because physical
education requirements, which usually occur outdoors, may exacerbate the illness. Being in the
sun increases the risk of lupus flare-ups, so accommodations may be necessary in order to limit
ultraviolet light exposure.
Lupus Nephritis
Lupus nephritis is a condition involving inflammation of the kidneys due to lupus
involvement (Walsh, 2018). It affects a "significant proportion" of children with lupus, and it is
the "most important predictor of morbidity and mortality" (Thakur et al., 2017). It also accounts
for approximately 60% of pediatric hospitalizations involving lupus (Walsh, 2018).
Our understanding of lupus nephritis has changed dramatically over the past 50 years
(Wenderfer et al., 2016). Rheumatologists are updating their treatments as research constantly
updates the strategies to keep the kidneys of young patients intact. Between 50% and 75% of
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pediatric patients with lupus experience lupus nephritis, or lupus with kidney involvement (Sinha
& Raut, 2014). A meta-analysis shows that pediatric patients with systemic lupus erythematosus
have a 10%-30% higher prevalence of developing kidney involvement than in adults, which is
why pediatric rheumatologists monitor the kidneys closely (Wenderfer et al., 2016).
Kidney biopsies are a means of gaining accurate information on the child's renal
functioning, and the results are much better interpreted than in the past. Children usually undergo
kidney biopsies under general anesthesia, while adults are locally sedated around the kidney site.
Three measures that are often used to assess kidney function include creatinine, urinalysis, and
glomerular hematuria (a key symptom of kidney disease). Wenderfer et al. (2016) reported that
these measures can be inaccurate, which is why a kidney biopsy is recommended for absolute
certainty regarding the level of impairment.
Cyclophosphamide, a type of chemotherapy, is often added to the treatment regime in
order to manage lupus nephritis (Sinha & Raut, 2014). The issue regarding access to medical
care is most evident in regards to renal transplantation (Hiraki et al., 2011). Kidney disease
relating to lupus nephritis accounts for 1.9% of all end-stage kidney disease patients (Sabucedo
& Contreras, 2015).
Cardiovascular Disease
Cardiovascular disease is the "number one cause of death" among all lupus patients
combined (Johns Hopkins, 2019). Lupus patients often experience an increased and premature
risk for atherosclerosis, where fatty substances progressively deposit on the inner artery walls
(Fogoros, 2018). They are also found to have cardiac abnormalities (Gunal et al., 2003). Children
born to women with lupus were found to have a higher rate of congenital heart defects too (Vinet
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et al., 2014). Premature atherosclerosis is a significant factor in mortality and morbidity in
children (Sandborg et al, 2008).
Inflammation is a key indicator of possible atherosclerosis. For that reason, dietary
changes must be established in order to prevent additional risk factors to the already elevated risk
for the pediatric patient (Sandborg et al., 2008). Questions remain as to whether additional
cardiovascular treatments are necessary in order to decrease that risk even more.
Multidisciplinary Care
Rheumatologists are usually the primary specialists who treat persons with lupus.
Rheumatology involves the treatment of a variety of autoimmune disorders, such as rheumatoid
arthritis and fibromyalgia. The variability of lupus requires rheumatologists to collaborate with
other medical specialists in the management of the disease. Ardoin and Schanberg (2012) stated
that youngsters with lupus require "specialized, multidisciplinary care.” The specialties that are
most commonly involved with lupus patients include nephrology, neurology, cardiology,
immunology, and hematology. Due to the lack of research on the epidemiology and management
of lupus, current best practice treatment is multifaceted, so there is constant collaboration and
communication among a treatment team of physicians. In addition to the physiological aspects of
disease management, youngsters also require attention to be devoted to the
developmental/psychosocial aspects of their functioning.
Transition of Care
Due to progress regarding improved survival rates, medical maintenance must be
established with a long-term perspective that can help patients transition medically and
developmentally. The transition from pediatric lupus to adult lupus care is a crucial process due
to the severity of the illness. Son et al. (2016) called for more studies to examine adolescent
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patients' transition from being under the care of pediatricians to adult physicians. Son et al.
(2016) examined this critical transition of providers, and found that depression and anxiety
increased significantly during the transition, from 10% to 26%. Contributing issues, such as
depression, fluctuating mood, health perceptions, and self-esteem, can negatively impact the
disease process.
The challenge of transitioning is evident through the gap of time between the last
pediatric provider to the new adult provider. According to Son et al. (2016), non-adherence to
treatment plans also has the potential to have dire consequences. Fredericks et al. (2008) stated
that special considerations must be made as the receiving rheumatologist adjusts to the medical
and socioemotional issues presented by the new patient. The young adult patient must learn to
make medical decisions and navigate his/her own healthcare independently. Those who are
entering young adulthood may find that navigating the adult world of healthcare can be a
challenge. Thus, it is important to be mindful of the age of the pediatric patient and the
circumstances surrounding not only the medical aspects of their care, but the psychosocial and
educational aspects of their care as well.
The transition process was examined by researchers in Italy in a study of 25 patients
diagnosed with pediatric lupus (Costagliola et al., 2018). Longitudinal data were collected for
approximately eight years. The most remarkable finding from this study centered on the
evolution of the disease progression. Pediatric patients who exhibited chronic organ damage had
more disease activity during the follow-up when prescribed a significantly higher dose of
corticosteroids. The authors suggested that pediatric patients with immune cytopenia (when the
level of a blood cell type is lower than it should be) require more "strict clinical follow-up for the
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risk of evolution to lupus" (Costagliola et al., 2018). They also emphasized the need for "intense
surveillance of renal function."
Sadun and Schanberg (2017) recommended having a "transition coordinator" to bridge
the treatment transfer in order to ensure continuity of care and the need for developing the
patient's self-management skills and ongoing medication compliance during the process.
Access to Quality Health Care
As mentioned earlier, one of the contributing factors to the outcomes of a disease such as
systemic lupus erythematosus involves access to healthcare. It is important to note that adequate
healthcare must be differentiated from quality healthcare. The Arthritis Foundation reported that
the number of rheumatologists is expected to decline over the next decade (Davis, 2020). The
5,415 rheumatologists who were registered in 2015 is projected to decrease to 4,051
rheumatologists by 2030. The number of rheumatology medical students is not large enough to
fill in for the number of rheumatologists who are preparing to retire over the coming years.
Because there are more rheumatologists in metropolitan areas, patients residing in
smaller, rural areas may not be able to have the same level of medical care. Because of the multiorgan impact of lupus, patients usually must have a multi-disciplinary team involving numerous
specialties to monitor multi-organ involvement. Thus, the necessity of living in an area with
access to a wide variety of medical specialists places extra constraint on the patient's ability to
access adequate comprehensive patient care.
Lawson and Yazdany (2012) listed possible factors that can directly or indirectly impact
patient outcomes. Insurance coverage is a major factor in both the adequacy and quality of care.
Insurance companies have the authority to make administrative decisions that may permit or
deny various forms of treatment which can ultimately benefit the patient. The LUMINA study
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alludes to the significant differences in mortality rate by identifying the specific factors of
insurance coverage and socioeconomic disadvantage (Bertoli et al., 2008).
Psychological Effects of Chronic Illness
Although an illness such as lupus prompts experts to think of the etiology and
immunological processes from a purely scientific and medical perspective, a recent study offers a
unique psychological perspective. A recent study resulted in a strong association between the
exposure to trauma (with or without a formal diagnosis of Post-Traumatic Stress Disorder) and
an increased risk of having lupus among adult patients (Roberts et al., 2017). A sample of 54,763
women were screened and the hazard ratio was 2.83 (95% CI 1.29-6.21, p<0.01). Childhood
trauma has also been linked to lifelong chronic illness in the Adverse Childhood Experiences
study (Nakazawa, 2016).
In this study of over 54,000 women, those who experienced a traumatic event had a twofold higher risk for lupus than those who did not. Those who displayed symptoms of PostTraumatic Stress Disorder had a three-fold risk. Stress, in general, has been recognized as
contributing to flare-ups of the illness. The psychoneuroimmunology behind this complex illness
needs to be practically examined in children and adolescents due to the potentially stressful
environment of school. Illness can affect interactions with teachers if an incorrect perspective is
fostered. For example, teachers may not understand the severity of the illness and assume that
the child is lazy and/or incapable.
In addition to monitoring the cognitive development of pediatric lupus patients, it
becomes necessary to monitor the psychosocial burdens (Levy, 2012). Proper psychological and
educational support must be factored into a holistic treatment plan. As for the psychosocial
burdens of pediatric patients with lupus, coping with a chronic illness may be challenging for
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patients within this age range. The regular challenges of trying to achieve in school and fitting in
among peers is complicated by factors such as pain/discomfort and medication side effects.
Having relationships with one's peers facilitates the growth of self-esteem and a sense of
acceptance and belonging (Rubin & Bukowski, 2011). Rhee et al. (2011) found that peer support
helped to generate more positive attitudes in pediatric patients with lupus.
The interwoven issues involving family and the acceptance of a chronically ill self can
complicate the disease process (Iliades, 2015). As for psychosocial burdens, it is important to
remember that chronic illness is challenging for any patient, but those in this age range must face
the additional challenges of sickness on top of typical adolescent struggles. Such struggles can
develop into serious complications within the disease process (Iliades, 2009). Resilience is the
aim for each patient, both in medicine and in education. Tunnicliffe (2016) discussed various
aspects of medical resilience for adolescents, including the following factors: gaining personal
independence, developing self-reliance, adjusting the perceived disease activity and/or ability,
dependence on others, and trusting the physicians who are their primary providers.
The effects of chronic illness on a child has been shown to foster depression and isolation
(Levy & Kamphuis, 2012). That is why the Lupus Foundation of America recommends that
pediatric patients be asked regularly about how they are feeling because they may need extra
psychological assistance, such as professional therapy. In the medical setting, medical social
workers are available to check in with patients. However, patients need to find affirmation of
their self-worth and value from teachers and parents as well (LFA, 2019).
A major factor that makes lupus patients more prone to “adverse psychological side
effects” is the use of corticosteroids as the main strategy for immunosuppression (Stuart et al.,
2005). Corticosteroids can cause labile mood, anxiety, and irritability (Warrington & Bostwick,
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2006). Kohut et al. (2013) reported that among children and adolescents, prednisone dosage was
found to be associated with negative self-esteem and somatic depressive symptoms. Few studies
have been conducted on these specific variables in childhood-onset systemic lupus
erythematosus.
Davis et al. (2018) examined the potential relationship between depression and
medication non-adherence. Demographics and disease characteristics were taken into account
during the analysis. The results from 51 questionnaires revealed that 58.8% experienced
depression. Seven patients revealed suicidal ideation, which accounted for 13.7% of the sample.
Patients who were willing to self-report their medication non-adherence equaled 19.7% of the
sample. No statistical differences were found among various demographic and disease
characteristics. Those who reported medication non-adherence were more likely to have longer
disease duration. The authors found that as the depressive symptoms increased, the degree of
medication non-adherence also increased. Consequently, there appears to be an important
association between depression and medication non-adherence in childhood-onset systemic lupus
erythematosus.
Because of the medications' impact on appearance, Ji et al. (2012) conducted a study on
84 adolescents with lupus and 80 healthy adolescents in China, where "appearance concern and
depression" were assessed via the Children Depression Inventory (CDI) and the Self-Perception
Profile for Children. The authors used correlation and multiple regression analyses to determine
that "appearance concern" was related to the increased likelihood of depression.
A qualitative study conducted by Harry et al. (2019) examined the needs of patients with
childhood-onset systemic lupus erythematosus by asking a simple question: "What are we
missing?" In order to answer that question, the authors involved 31 patients whose ages range
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from 12 to 24 years in a Midwestern Children's Hospital. Ten major themes were revealed from
the established focus groups, which included: “knowledge deficits about childhood onset
systemic lupus erythematosus, symptoms limiting daily function, specifically mood and
cognition/ learning, barriers and facilitators of adherence, and worry about the future.” There
were additional themes that were unique to the adolescent/young adult participants, and they
included symptoms that limited their daily functioning, such as pain, fatigue, self-care, impact on
relationships, and communication with health providers.
As for the caregivers in this study, the themes that resulted from their input included the
need for educational advocacy, consistent family schedules, and a sense of typicality or normalcy
for their child (Harry et al., 2019). The American study conducted by Harry et al. (2019) and the
Australian study conducted by Tunnicliffe (2016) demonstrated common themes despite the
geographical differences. The authors specifically describe how frequent absences or even
inadequate grades can have an "enormous impact on a child’s psychological development and
quality of life" (LFA, 2019).
Psychological and Socioemotional Factors in Lupus
Although psychometric information, structured interviews, and clinical observations may
offer professional insight into the level of functioning within pediatric lupus patients, examining
patients with lupus through a contextual lens remain important. Stress, in general, has been
recognized as contributing to flare-ups of the illness (LFA, 2019). Stress can also impair immune
activity and produce increased inflammation and cytokine release (Feldman et al., 2018). For
example, a longitudinal study conducted by Feldman et al. (2018) found that women and
children who were abused during childhood had an increased risk of developing systemic lupus
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erythematosus. That longitudinal study correlates with previous findings regarding stress and
lupus (Feldman et al., 2018).
There are a limited number of studies involving pediatric psychoneuroimmunology.
Those studies that have been conducted demonstrate parallels to studies on
psychoneuroimmunology in adults. Different types of stressors with differing timeframes of
stress appear to produce different effects on the immune system (Herbert & Cohen, 1993).
Stress has been shown to cause dysregulation in the immune systems of children with various
chronic illnesses, such as lupus and asthma (Nassau, Tien, & Fritz, 2008). Miller and Cohen
(2001,p.47) have found “modest evidence” that psychological interventions can alter immunity.
Studies have even shown that children can learn self-regulation strategies that can positively
impact the immune system, even some activity which were thought to be under autonomic
control (Gertz & Culbert, 2009).
The psychoneuroimmunology behind this complex illness is important to understand as
the association of school and lupus are linked when considering pediatric patients. Because of
the legal mandate of school attendance, pediatric patients must comply with educational
requirements despite their treatments. School is often viewed as a highly stressful environment,
even for healthy students. Preidt (2019) found that stress and negative childhood experiences
contribute to active lupus disease progression. That finding indicates a need for increased
attention to the psychological well-being of all lupus patients, regardless of age or ethnicity.
The United Kingdom developed the "Educational Needs Assessment Tool," and a Dutch
version was adapted from that measure (Zirkee et al., 2014). They used the "Educational Needs
Assessment Tool" (ENAT) to objectively assess the educational needs of students with
rheumatological conditions. Their sample of 244 students with lupus contributed to the discovery
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of patients' "substantial educational needs". The various domains that were found to be
statistically significant included "self-help measures," "disease process," and "feelings." This
practical discovery is applicable to the present study in justifying the need for further
investigation of pediatric patients and their perceptions of school experiences (Zirkee, 2014). For
pediatric patients, school can be a key element in their quality-of-life functioning.
A study focusing on quality-of-life issues among adolescents was conducted by
Tunnicliffe et al. (2015) in five Australian hospitals from 2013 to 2014. This qualitative study
utilized focus groups and interviews for thematic analysis. Five themes were identified by the
researchers based on the participants’ responses. The title is representative of the underlying
challenges which relates to the themes of the study: "Lupus Means Sacrifices." The themes
which emerged from the patients' responses included (Tunnicliffe et al., 2015):
- "Marring Identity": Sense of isolation and misrepresentation of the self; Selfconscious beyond what is typical for adolescents
- "Restricting major life decisions": Limited career options; Possible risks
regarding parenthood
- "Multifaceted confusion and uncertainty": Delay of diagnosis; Uncertainty
regarding symptoms; Ambiguity regarding prognosis; Longing for remission
- "Resentment of long-term treatment": Discontent with long-term medication
use; Irritation about medications’ side effects
- "Gaining resilience and coping strategies": Dependence on loved ones for
support; Development of trust in the treating physicians; Learning ways to cope
with the presenting challenges of the disease
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The significance of this study lies in the fact that the responses of this population of late
adolescent and early young adult patients with lupus are quite similar to full-grown adults with
lupus. Similar themes were identified. Because of those issues, pediatric patients with lupus
reported to have a lower quality of life than same-aged students without lupus (Tunnicliffe et al.,
2015).
Ji et al. (2012) conducted a study on 84 adolescents who have SLE and 80 healthy
adolescents in China, and "appearance concern and depression" were assessed via the Children
Depression Inventory (CDI) and the Self-Perception Profile for Children. The authors used
correlation and multiple regression analyses, and found that both factors contributed significantly
to the increased likelihood of depression.
Lupus can also prompt feelings of anxiety and depression due to the constant uncertainty
and unpredictability of the illness. Even those in remission may be fearful about flare-ups, which
can occur at any time. Anxiety was found to be "a vulnerability factor" for depression (Lember,
2015). Zhang et al. (2017) conducted a systematic review and meta-analysis, and their
conclusion was that the symptoms of anxiety and depression are so high in patients with lupus
that they recommend routine psychological screenings for patients with lupus.
A cross-sectional study of young patients with lupus and healthy children resulted in a
statistically significant difference in level of suicidal ideation (Knight et al., 2014). The results
indicated that 14% of youth with lupus had suicidal ideation, whereas only 4% of the healthy
participants had such thoughts. Studies such as these raise questions as to whether the
rheumatologist, the school counselor, school psychologist, or others should regularly check on
the adolescent patients’ ability to emotionally cope with all of their medical challenges.
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Neuropsychiatric Lupus
According to Brunner and Klein-Gitelman (2009), neuropsychiatric lupus (NP-SLE) is
“arguably the least understood manifestation of SLE” and they describe how NP-SLE presents
through a very wide range of clinical presentations. These presentations can range from central
nervous system disorders to cognitive dysfunction to peripheral nervous system disorders.
According to Brunner and Klein-Gitelman (2009), 95% of pediatric patients manifest at least one
symptom of NP-SLE.
The most common NP-SLE symptoms include headache and neuro-cognitive
dysfunction. Manifestation of the symptoms may exhibit through impairment of attention,
reasoning, sequencing, visual-spatial processing, recall, language, and psychomotor speed. Yu et
al. (2007) conducted a 20-year longitudinal study that examined the neuropsychiatric
manifestations among participants (n=185). They found that the most frequent types of
neuropsychiatric manifestations include seizure disorder (84.4%), ischemic stroke (28.1%), and
psychosis (21.9%) in pediatric systemic lupus erythematosus (Yu et al.,2007).
The American College of Rheumatology has recognized 19 specific neuropsychiatric
syndromes that are linked with systemic lupus erythematosus. However, the established
diagnostic criteria (based on the 1982 American College of Rheumatology), recognizes only two
of them, and they happen to be neuropsychiatric in nature. They include psychosis and seizures
(Popescu & Kao, 2011). Because of their specific inclusion in the diagnostic criteria and because
of their possible impact on a pediatric patient’s neurological development, neuropsychiatric
functioning is considered to be very important due to its developmental implications for learning.
Children may present with some form of neuropsychiatric problems within the first few years of
diagnosis (Toruner, 2017).
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Neuropsychiatric lupus (NP-SLE) was described by Popescu and Kao (2011) as being
"the least understood, but perhaps the most prevalent manifestation of lupus." They reported that
it affects 22% to 95% of children, and these numbers are higher than adults. These researchers
estimated that approximately 80% of adults with lupus present with NP-SLE syndromes
involving the central nervous system and that approximately 95% of pediatric patients manifest
at least one symptom of NP-SLE.
NP-SLE often develops early on during the disease progression, and about one-fourth of
patients manifest symptoms within 30 days of the initial diagnosis. The severity of the symptoms
can range from "mild impairment to severe dementia". Neuropsychiatric complications occur
more frequently among children than among adults, which hold great implications for their
learning process and their education. Neuropsychiatric lupus is also associated with increased
mortality among patients.
According to Brunner and Klein-Gitelman (2009), NP-SLE is associated with a complex
range of symptoms. This condition may present through symptoms such as cognitive
dysfunction, seizures, psychosis, depressive disorders, and headaches. The most common NPSLE symptoms are headaches and neurocognitive dysfunction (Brunner and Klein-Gitelman,
2009).
As for the etiology of NP-SLE in pediatric patients, the route of the disease activity is
unknown at this time. Neurological complications for pediatric lupus patients often lead to an
increased chance of morbidity and poor long-term consequences. One possible explanation
involves the multi-faceted nature of neurocognitive dysfunction, which can involve the medical
aspects of autoimmunity, such as auto-antibody production, microangiopathy, intrathechal
production of cytokines which promote inflammation, and even atherosclerosis. Although
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elevated cerebrospinal fluid levels of pro-inflammatory cytokines have been documented, the
manner in which these cytokines impact the brain remains unknown.
The definitions for these syndromes were classified into two broad categories by the
American College of Rheumatology in 1999: central nervous system and peripheral nervous
system. The NP-SLE disorder relating to the central nervous system include, but are not limited
to cognitive disorders, seizure disorders, psychiatric disorders, and headaches. NP-SLE relating
to the peripheral nervous system include, but are not limited to cranial neuropathy, sensorineural
hearing loss, and myasthenia gravis (Muscal & Brey, 2010). These disorders may explain why
the prognoses of patients with NP-SLE often is negative due to cumulative neural/physical
damage.
Besides psychosis and seizures, other central nervous system events may include
headaches, cognitive dysfunction, mood disorder, anxiety disorder, acute confusional state, and
aseptic meningitis (Popescu & Kao, 2011). For patients who experience such manifestations of
central nervous system involvement, the treatment plan typically is to use high-dose
glucocorticoids, intravenous cyclophosphamide pulse therapy, along with minimal use of
corticosteroids, although there is a lack of consistency in the approach to managing central
nervous system lupus. Having good differential diagnosis skills is crucial to treating NP-SLE,
however, those symptoms often resemble classic mental illness and may be mistaken for
psychological issues (Magro-Checa et al.).
Although neuropsychiatric involvement is common among patients with systemic lupus
erythematosus, less than one-third of these events have been directly linked to it. Magnetic
Resonance Imaging (MRI) tests are used to assist with the diagnostic evaluation, and blood tests
can also reveal the extent of an inflammatory state. There is current research to better assist with
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the biomarkers and pathologic mechanisms that can better provide evidence of the lupus-induced
neuropsychiatric activity.
For example, Unterman et al. (2011) found that neuropsychiatric syndromes were evident
in more than half of adult patients in their sample. The manifestations that were most commonly
exhibited were headache, mood disorders, and cognitive issues. Significant differences were
found for prevalence rates, which ranged from 12% to 95%. This finding may be due to the
various screening methods, the baseline population, and the severity of the illness (Unterman et
al., 2011).
Another concern/side effect of treatment is steroid psychosis. Steroid-induced psychosis
can mimic NP-SLE, which is why the process of finding the correct differential diagnosis can be
challenging. Stuart et al. (2005) reported that steroid-induced psychosis occurs in approximately
5 to 6% of adult patients who take that medication. The approximate figure for psychiatric issues
range from 25% to 60% of pediatric patients who have systemic lupus erythematosus (Stuart et
al., 2005).
Prior to modern-day research, it was thought that “steroid psychosis” was not evident in
the pediatric population (Stuart et al., 2005). Eventually, Stuart et al. (2005) observed 16 cases of
“steroid psychosis” in pediatric patients who were receiving “pulsed intravenous
methylprednisolone,” which is commonly prescribed to pediatric patients. A review of the data
showed that “adverse psychological side effects” manifested in children and adolescents a few
days after the treatment was implemented (Stuart et al., 2005). This form of psychosis is usually
induced by the consistent use of corticosteroids (Stuart et al., 2005). The manifestation is similar
to typical psychosis.
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Pediatric Neurocognitive and Psychoeducational Functioning
As discussed above, the presence of “adverse psychological side effects” covers a wide
spectrum of symptoms that can manifest into serious levels of impairment in children. Before
discussing pediatric patients’ psychoeducational issues, it is important to understand the
neurological challenges that can directly impact the learning process of young patients with
lupus in the school setting. Due to the cognitive impairment that is often associated with
neuropsychiatric systemic lupus erythematosus (NPSLE), the practical manifestations of the
illness can emerge as formally recognized learning disabilities or informally recognized learning
challenges. Several recent studies have forged a growing link between autoimmunity and various
brain disorders, which can affect the patient’s learning ability.
Cavasos-Garcia & Brey (2004, p.3) reported that “estimates of the prevalence of NPSLE
have ranged from 14% to over 80%.” However, these issues may also manifest without signs of
systemic disease activity (Muscal & Brey, 2010). Statistics regarding neurological manifestations
have varied quite dramatically, due to the manner in which cognitive testing is conducted. When
neuropsychiatric testing was completed on lupus patients, it consistently produced higher
numbers of cognitive impairment compared to other types of assessments (Benedict et al., 2008).
At this time, the reliability of neurobehavioral diagnoses remains vague due to the lack of
reliable tests for detecting neurobehavioral syndromes that are specifically linked with lupus.
Brunner and Klein-Gitelman (2009) offered a possible explanation for the lower
cognitive functioning among lupus patients by noting that the onset of lupus coincides with
typical neural cognitive development in children. Neuroimaging studies show that adolescent
brains do not mature until their twenties (Johnson et al., 2009). Because of the cognitive
development that occurs during this time period, it is important to observe any changes in
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memory and learning patterns. Consequently, it is possible that the neurocognitive issues are
causal and/or related to lower test scores and low overall executive functioning and working
memory. In addition to lower executive functioning, Williams et al. (2011) found significant
impairment with psychomotor speed and fine motor skills.
Conti et al. (2012) reported that cognitive impairment can impact children and
adolescents in almost every cognitive task, such as reading comprehension, academic
performance, and intelligence. The neuronal dysfunction can impact processing skills which will
impact the academic task at hand. These processing skills include visual memory and attention.
Pediatric patients rarely undergo comprehensive psychoeducational evaluations so the extent of
the cognitive limitations are rarely examined (Conti et al., 2012).
One aspect of a lupus patient’s learning process which may be impaired involves the
cognitive challenges that often occurs with lupus (Benedict et al., 2008). This impairment is
generally known as “lupus fog”. The specific areas which are associated with lupus fog include
speed of information processing, working memory, visual/spatial memory, and memory, in
general (Benedict et al., 2008). Memory can be impacted, either from the illness itself or as a
result of pharmacological side effects. Patients with lupus often have difficulty with maintaining
sustained attention to tasks, which medications likely exacerbate (Barraclough et al., 2019).
At this time, demographic factors do not appear to be predictive of neuropsychiatric
issues in patients. There is no identifiable evidence of any consistent pattern relating to
neuropsychiatric impairment. Comorbid psychiatric disorders with SLE are a valid possibility to
explain the neuropsychiatric symptoms. Zelko (2012) reported that lupus can impair cognitive or
psychiatric functioning during both childhood and adulthood. Neurocognitive dysfunction is
elevated among patients with lupus in comparison to norms from the general population. This
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issue has been found in matched cases comparing demographic factors. Iliades (2009) estimated
that cognitive impairment occurs in child and adolescent patients at a rate of 59%.
Zelko (2012) conducted a study involving 40 pediatric patients with lupus and 40 samegender best friend control participants. This matched design allowed for direct comparison of the
40 children and adolescents with a comparable control group. The participants were evaluated
based on their demographics, academic functioning, behavioral and emotional functioning, and
self-help functioning. In addition to having lower academic functioning, parents' ratings of
school competence (as measured by the Child Behavior Checklist) was lower among patients
with lupus then their best friends. The control group and the pediatric patients with lupus did not
differ significantly on measures of cognitive, behavioral, emotional, or executive functioning.
Pediatric patients were matched according to demographics, and those with SLE had
significantly inferior academic outcomes, compared to comparable controls (Zelko, 2012).
The authors noted that school attendance and the side effects from serious treatments can
impact the patients’ academic functioning. The authors concluded that pediatric patients “do in
fact experience poorer academic outcomes than demographically-matched healthy peers, and that
cSLE disease severity and treatment intensity are associated with school competence” (Zelko,
2012, p.1174).
Neurobehavioral disorders involve a large group of behavioral impairments that is
associated with some type of brain injury or brain disease (Zasler, 2013). Symptoms of central
nervous system (CNS) involvement may include loss of memory, concentration, attention,
cognitive processing, and clear thinking. Due to the level of variability of the illness and
variability of the medication(s) and dosages, which fluctuates according to periods of remission
and flares, pediatric patients' cognitive functioning may not be as consistent as with other
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students. Thus, educational plans may need to be updated according to changes in students’
medical status.
Boston Children's Hospital reported that up to 75% of patients with SLE experienced
neuropsychiatric symptoms. The reason for such high numbers remained a mystery until a
discovery which “has huge implications for a range of central nervous system diseases." (Carroll,
2017). Carroll (2017) discovered a "surprising new link between inflammation and mental
illness" by using a mouse model of lupus to that connected inflammation to mental illness.
Neurobehavioral disorders involve a large group of behavioral impairments that is associated
with some type of brain injury or brain disease (Zasler, 2013).
Carroll and his team found that adequate interferon alpha was able to permeate the bloodbrain barrier and cause physical changes in the brain. Once it crossed the barrier, it was able to
launch microglia, which is the immunological defense cells of the central nervous system.
Microglia can be transformed into an attack mode on the neuronal synapse of the brain, which
may cause synapses to be lost in the frontal cortex. Microglia dysfunction has been observed in
other mental illnesses, such as schizophrenia. The research team attempted to reduce the loss of
synapses by using a drug that blocks the interferon Alpha receptor, commonly known as “anti ifnar.” It was discovered that the anti - ifnar offered some neuroprotective effects in mice with
lupus by preventing the loss of synapses. Thus, this study offers immunological insight into the
neuropsychiatric symptoms of CNS lupus (Carroll, 2017).
One hundred twenty-eight pediatric rheumatologists were surveyed regarding their
pediatric patients with CNS involvement. The results from the surveys indicated that 98% of
those pediatric rheumatologists preferred to have formal testing completed for pediatric patients
who show academic or cognitive issues (Brunner & Klein-Gitelman, 2009). However, there is
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currently no standardized battery of neuropsychological tests which can be used as a valid and
reliable measure of cognitive dysfunction in pediatric lupus patients, so diagnosing such a
condition can be challenging among the pediatric population (Rubinstein, 2015). The Childhood
Arthritis and Related Diseases Research Agenda (CARRA) Lupus Neuropsychiatric working
group is currently working on establishing a valid battery of standardized measures (Rubenstein
et al., 2015). Research is also being done to find non-invasive biomarkers which may indicate the
level and specific type of neurological impairment(s).
School and Systemic Lupus Erythematosus
For pediatric patients, school is one of those issues that must be addressed due to its
possible impact on the patients' health. During the 1950's, children with juvenile rheumatoid
arthritis (JRA) were encouraged to be educated at home or be enrolled in special classes (Lovell
et al., 1990). Nowadays, most pediatric patients with rheumatic conditions are able to thrive in
general education classes with the support of a 504 Plan or with special education services.
Barraclough et al. (2019) wrote that "any therapeutic interventions should be individually
tailored" for patients with SLE.
Moorthy et al. (2010) reported that 83% of pediatric lupus patients in their study stated
that they would have performed better in school had they been illness-free. That statistic
demonstrates how students with lupus may not be able to achieve according to their academic
potential due to their illness. Because lupus is a chronic condition, it will continue to impact the
student into their college years and may determine if they can even attend college.
Education is an important factor in an adolescent's life, because those skills of childhood
will gradually transfer into the occupational skills of adulthood. A successful educational career
may open doors to future occupational options and opportunities. Occupational options are
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limited otherwise due to the physical, cognitive, and financial constraints of chronic illness
(Parks & Cooper, 2006). Morasso (2014) reported that students with chronic disabilities tend to
have lower college graduation rates (46.9% vs. 51.7% in healthy peers) and lower persistence
(staying in college) rates (55.3% vs. 59.2% in healthy peers). Childhood-onset lupus patients
have been shown to have lower socioeconomic success than their healthy peers due to an
inability to participate in higher education or the need to limit work hours for health reasons
(Ravelli et al., 2005).
Tunnicliffe et al. (2015) stated that students with systemic lupus erythematosus have to
restrict their goals and perspective of their future in terms of careers and activities. For example,
lupus patients must take great care when choosing an occupation because certain substances may
exacerbate the illness, such as silica, solvents, pesticides, and sunlight. (Parks & Cooper, 2006).
The U.S. Department of Education (2005) reported that approximately half of students with
disabilities who enrolled in post-secondary schools remained silent about their status of having
disabilities by not informing their schools. Consequently, they were not provided with any type
of service from disability offices on their campuses (Morasso, 2014).
The link between education and pediatric healthcare has not frequently intersected in the
United States. Gavin (2015) reviewed recommendations on what teachers can do for students
with lupus and provided a brief and general paragraph entitled "What Teachers Can Do”. The
main points in that brief paragraph warned educators that students may feel more "tired, sick,
feverish, and achy than usual" (LFA, 2019). However, the only recommendations that were
offered were to have the lupus patient rest or be excused from strenuous tasks and/or activities.
Now that many patients' life expectancy are lengthened due to improved treatments, it is
even more important to examine quality-of-life issues, such as school, in light of lupus. The topic
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of school is significant to most young patients' lives for both educational and medical reasons. In
addition to being exposed to the curriculum, lupus patients are being exposed to countless
bacteria and viruses on a daily basis, for a significant portion of their day. School then poses as a
possible health hazard to immunosuppressed patients.
A study conducted by Zelko et al. (2012) revealed that children who have lupus
demonstrated "inferior academic performance" than their healthy peers. It is not certain whether
actual cognitive deficits account for the difference or not. For example, Frittoli (2016) reported
that patients with lupus who experienced some form of cognitive dysfunction demonstrated a
significant worsening of their mathematical skills. Frittoli's sample of 41 patients with lupus had
a 41.46% rate of cognitive dysfunction. The conclusion of the study was that patients who
exhibited concomitant cognitive dysfunction and lupus experienced worse mathematical skills
than those without those issues. Because a pediatric patient's school attendance may be impacted
by treatments and hospitalizations, it is not clear if the mathematical deficits would be restored or
not during the remission phase of the illness.
Lupus patients may need to be absent more frequently than other students due to hospital
stays for intravenous chemotherapy, medical tests, and/or medical appointments. By missing so
much school, it can take a toll on patients' academic performance (Frittoli, 2016). Systemic lupus
erythematosus involves extensive variability. The medical status of the patient fluctuates, so
absences are often unpredictable. Missed days of school tend to result in extra work and extra
stress for the student due to the necessity of completing current schoolwork, in addition to
missed schoolwork. The significance of school also lies in the fact that students' "lessons" may
also involve indirect lessons on socialization, communication, and conflict resolution.
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Consequently, the school environment carries comprehensive benefits for the personal
development of young patients, in terms of their academic and socioemotional functioning.
Studies on pediatric lupus patients indicate that they achieve worse academic outcomes
than same-aged peers (Frittoli et al., 2016, Zelko, 2012). These results are not necessarily due to
low intelligence or neurological damage. With the accumulation of missed assignments, students
with lupus may experience extra stress and pressure, which can contribute to flare-ups of the
illness. Disease progression and flare-ups can then take a cyclical turn and worsen patients'
academic performance. The chronic-relapsing course of the illness also interferes with a patient's
stamina and educational progress.
No research addressing accommodations or effective strategic interventions for students
with lupus has been conducted. School can be stressful for youngsters. Decreased stress and
anxiety can lead to less autoimmune activity, and the possibility of remission (Levy, 2012).
While this formula may not occur in such a clear-cut manner, the emphasis remains on the
connection between the psyche and the immune system. That connection remains sensitive and
active in the school environment, regardless of the patient's efforts or awareness.
Zelko (2012) conducted a study with 40 adolescent patients with lupus and 40 samegender best friend control participants. The participants were evaluated based on academic
functioning, behavioral functioning, emotional functioning, and executive functioning in daily
life. In addition to having lower outcomes of academic functioning, parents’ ratings of school
competence, as measured by the Child Behavior Checklist (CBCL), were lower among patients
with lupus than their matched best friends. The mean scores were within the normal range, but
there was a higher level of variability in the scores among the patients.
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As for cognitive, behavioral, emotional functioning, and executive functioning, Zelko
(2012) found that the lupus patients did not show significant differences in lupus patients' levels
of performance. Standardized tests, such as the Child Behavior Checklist (CBCL), Behavior
Rating Inventory of Executive Function (BRIEF), and Child Depression Inventory (CDI), were
used to assess their functioning. The results of cognitive testing indicated the lupus group had a
statistically significant weakness on the indices of Wechsler's "Working Memory" and
"Processing Speed". They also had significantly higher scores on the CBCL's "Externalizing
problems" and the BRIEF’s "Behavior Regulation" indices and on the CDI measure of "Overall
Depressive Symptoms". On the Wide Range Assessment of Memory Learning (WRAML)'s
“Memory Screening Index”, the scores from the lupus group were higher than the control group.
According to Zelko (2012), the key factors which were associated with impaired
educational performance were disease activity/severity and treatment intensity. The lupus group
did not show other significant differences from the control group in terms of cognitive,
emotional, behavioral, or executive functioning (Zelko, 2012). However, Dos Santos et al.
(2010) found that a juvenile population of SLE patients had impaired verbal ability, which may
impact all of those elements of daily functioning.
Although poor school performance can be a result of neuropsychiatric issues, Zelko did
not find evidence that those issues are the catalyst for impaired academic functioning. This study
did not examine attendance, but Zelko (2012) reported the possibility of attendance issues
impacting the child's academic performance. It was specifically mentioned that disease activity
and corticosteroid treatment are associated with poor school functioning. The authors of the
study acknowledged that their definition of academic outcomes was based on a single measure
and from a single informant, notably the parents.
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Because the impact which lupus has on a patient's education has not been studied very
much, some insight can be gained from comparable conditions such as juvenile idiopathic
arthritis (JIA), which often affects those with lupus. Chomistek et al. (2017) reported that those
with juvenile idiopathic arthritis reported that their school attendance and performance were only
minimally impacted by their medical appointments and symptoms of their illness (n=98).
Instead, 42% of students with juvenile idiopathic arthritis reported that school was challenging
due to the physical aspects of the illness (Chomistek, 2017).
Even though statistics are not available regarding the number of patients with lupus who
have had special accommodations or services, there are studies that indicate such needs for the
children of mothers with lupus. Lahita (1988) found that 45% (24/55) of sons of lupus-stricken
mothers had a learning disability, such as dyslexia and that 10% of lupus patients' brothers had a
learning disability. The study revealed that 12.5% of lupus patients often exhibited a learning
disorder or dyslexia themselves. Lahita (1988) also reported that lupus patients were slightly
more likely to be left-handed than the general population. The prevalence of autism in children
of lupus patients is twice the number of the general population. All of these statistics may
collectively explain why the number of children born by mothers with systemic lupus
erythematosus require special education services in increasing numbers (Marder et al., 2014).
Zelko (2012) described the level of research in the area of education and lupus as being
"surprisingly limited". He added that there is significant reason to be concerned about their
academic outcomes due to the lack of occupational success on a long-term basis, a higher rate of
mental illness as they enter adulthood, and even substance abuse. Quality of life studies are
limited for minors with lupus.
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Moorthy (2010) examined 41 pediatric patients with lupus using the "Simple Measure of
Impact of Lupus Erythematosus in Youngsters", otherwise known as the SMILEY. Patients
answered questions relating to school attendance and academic performance. According to the
responses, patients reported having challenges related to their schoolwork. They also
acknowledged their memory issues, which make learning and the ability to focus difficult.
In general, the patients self-reported that they were sad about the impact that lupus had on
their schoolwork and attendance in class. Eighty-three percent of participating patients felt that
they would have done better in school had they not had the diagnosis of lupus. Their study also
found that patients who had intravenous chemotherapy had more absences then those who only
took oral medications. Intravenous chemotherapy usually requires an overnight stay in the
hospital. Those who missed the most school days also had the most disease activity.
Social Skills and School
Pediatric patients who have lupus reported having a lower quality of life than the typical
student. Tunnicliffe (2016) recruited twenty-six pediatric patients to participate in either a focus
group or a semi-structured interview. Results indicated that reasons for the lower quality of life
include concerns over physical health, self-esteem, and school. Because the study targeted
adolescents, self-esteem is a factor in their self-perception, which may relate to changes in their
appearance (Tunnicliffe, 2016). School and worry are linked due to expectations regarding their
academic performance.
School is a common place for children to establish peer friendships. Consequently, being
absent from school equates with being absent from friends and classmates. Children often learn
social skills through interactions with their peers during the school - aged years (Levy &
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Kamphuis, 2012). With lupus patients, peer support is more challenging to obtain due school
absences, which can lead to feelings of loneliness and isolation.
Medical isolation is sometimes mandated by physicians due to the use of
immunosuppressive medications such as chemotherapy. Isolation extends beyond just the
medical sense, because peer isolation also impacts the patients’ psyche. Peer relationships may
not be ideal due to the lack of consistency of interaction. One study noted that there is no
information for any specific interventions which can help the pediatric patients forge increased
friendships and involvement in social activities (Nabors et al, 2015). However, the use of social
media has helped with patient socialization (Pollio & Sciolla, 2019). The feeling of
connectedness may allow a smoother transition back into school. Al-Sheyab and colleagues
stated that a “peer-led education and support group” would be beneficial for a pediatric patient's
“health-related quality of life, self-efficacy to resist negative health behaviors, and knowledge of
best practices for illness management” (Nabors et al, 2015).
Building self-esteem can help alleviate feelings of loneliness and depression. Research
assessing the social needs of children with general chronic illness shows that peer support can
benefit them in the school environment (Nabors et al, 2015). Nabors et al, (2015) also reported
that classmates who are educated about the medical condition of the child who is ill are more
likely to be sympathetic to his/her needs. Parents should collaborate with the school staff, such as
the school nurse, on what would be developmentally appropriate for classmates to know in light
of privacy laws (Nabors et al., 2015).
Nabors et al. (2015) stated that medical staff should consider the child’s quality of life
during medical visits by asking about their functioning at school. The authors noted that this is
an indirect way of checking on the child’s emotional and social functioning. Knowing that
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information is a means of monitoring distress, which can help prevent a possible flare-up of the
illness (Nabors et al, 2015). The Lupus Foundation of America also recommends good parentteacher communication for adequate disease management (LFA, 2019).
Educational Accommodations
The present study strives to answer questions surrounding the topic of accommodations
in the school setting. Adult patients with systemic lupus erythematosus make up approximately
20% of Americans with a work disability (Agarwal & Kumar, 2016). Because lupus affects the
patient’s ability to work in a "profound" manner, concerns were raised by Agarwal and Kumar
about the younger population with this illness.
In addition to the obvious physical burdens of lupus, the financial and psychological toll
continues to impact patients for a lifetime (Agarwal & Kumar, 2016). According to 393
respondents to an online survey, the main challenges of maintaining a full-time job are the
fluctuation of the disease cycle, physical fatigue, and feeling "invisible" (Booth et al., 2018).
Every respondent reported that lupus had a “detrimental” effect on their ability to work, and
40.45% left their employment due to the illness. By understanding the impact this disease has on
adults, parallels can be drawn for the pediatric population as special consideration is given to
their future outcomes.
The terms "accommodation", "modification", and “intervention” have been widely used
in various contexts, which may encompass both educational and occupational realms. However,
only an accommodation can be present on both 504 Plans and Individualized Education Plans
(IEP’s). Accommodations can be legally carried from childhood into adulthood. A literature
review conducted by Harrison et al. (2013) systematically produced the best definitions for all
three terms based on their established criteria for the terminology. Accommodations differ from
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modifications and interventions, because the curricular expectations remain the same as other
students. Their distinct definitions are as follows (Harrison et al., 2013, p. 556):
Accommodations: "Changes in practices that hold a student to the same
standard as students without disabilities (i.e. grade-level academic content
standard) but provide a differential boost (i.e. more benefit to those with a
disability than those without) to mediate the impact of the disability on
access to the general education curriculum (i.e. level the playing field)"
Modifications: "Changes to practices in schools that alter, lower, or reduce
expectations to compensate for a disability"
Interventions: "Changes made through a systematic process to develop or
improve knowledge, skills, behaviors, cognitions, or emotions"

The University of Kansas offered an organized approach to defining "accommodations"
by outlining four classifications of accommodations. The first category is entitled "Presentation
Accommodations." This type of accommodation allows students to understand material without
the need to visually decode it by using standard print. The second category is called "Response
Accommodations," and this allows students to complete work and turn it in using an alternative
format or device. "Timing/Scheduling Accommodations" allow changes involving time when
dealing with due dates or the length of time required to complete projects, tests, and assignments.
The final category is "Setting Accommodations", which involves the setting where the
instruction or testing will occur.
Although legal mandates have been established to address workers with disabilities, it is
unclear if lupus patients know they can have practical accommodations. Numerous lupus
foundations and agencies recommend that pediatric patients request for accommodations to be
applied into their educational program. However, statistics regarding their actual implementation
are unavailable. The level of treatment fidelity by the teachers who are supposed to provide such
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accommodations are also presently unknown. At minimum, the present study seeks to gather
data on patients who are able to access some form of support for their education.
Because school can be stressful and having stress can trigger more autoimmune activity,
it is important to alleviate or ease any stressors at school for the sake of improving the pediatric
patient's quality of life. The decreased stress may even prolong their life. Improving the patient's
school experience can also facilitate feelings of competency and lower anxiety and depressive
symptoms. The interwoven effects of psychoneuroimmunology may then facilitate resilience via
the mind and the body.
Providing educational accommodations for students with medical illnesses is complex
due to the limitations of medical privacy (HIPAA). School staff members are required to abide
by this federal law, and parents may offer medical information for safety reasons. Cunningham
and Wodrich (2006) reported that detailed and relevant educational accommodations, which
pertains to a child's illness, is associated with the amount of known medical information by the
teacher. Consequently, increased details regarding the child's educational and medical needs
often resulted in more disease-centered accommodations.
Chapter Summary
The results of this literature review indicates there is value and a great need for studying
the topic of educational accommodations for students with systemic lupus erythematosus. This
illness is marked by severe fatigue, a “butterfly rash”, photosensitivity, inflammation, and organ
involvement. These symptoms can interfere with a young patient’s performance in the
classroom. This life-threatening autoimmune illness can have a potentially deep impact on a
patient’s basic functioning in daily living. Due to the spectrum nature of the illness and the
variability of organ involvement, the prognoses of students will vary. Statistics show that lupus is
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generally more severe and more deadly among pediatric patients than among adult patients. The
majority of pediatric patients will survive, but struggle with ongoing symptoms. Because of that
fact, extra support may be necessary in the school environment, which is why educational
accommodations are a key means of providing that support.
It is important to differentiate educational accommodations from other supportive
strategies such as modifications and interventions. Educational accommodations hold students to
the same curricular standards as other students. However, they provide “a differential boost…to
mediate the impact of the disability on access to the general education curriculum” (Harrison et
al., 2013, p.556). Because lupus symptoms often do not manifest in an obvious manner,
questions remain as to whether students with lupus are given appropriate accommodations,
which may ease their autoimmune symptoms and facilitate their learning.
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Chapter Three: Methodology
Overview of Survey Administration to Minors
Surveys are a very useful tool for gathering information due to the ease of extracting
first-hand, or primary, information from a participant. The medical field has increased the use of
surveys as a data-collection tool for research in recent years (Colbert et al., 2013). Because of
this, surveys have come to be "one of the most frequently employed study designs in healthcare
epidemiology research" (Safdar et al., 2016). This methodology chapter's sequence will involve
an examination of the constructed survey, the basis and reasoning for the chosen survey format,
the practical details of data collection, and the summary of the participants in terms of each
demographic variable.
According to DeFranzo (2012), there are many advantages to using surveys. For
example, surveys are not as costly as other means of research. The possibility of capturing
detailed information from a large population is also appealing to researchers. The variability and
flexibility of the survey design allows it to be adaptable to the chosen research questions.
The ease and flexibility of surveys are made possible due to the beneficial use of
technology (DeFranzo, 2012). Incorporating technological advances may benefit survey
methodology. The most frequently utilized form of survey research in healthcare epidemiology is
the online survey (Safdar et al., 2017). Computer software allows surveys to be disseminated
globally and they can be statistically analyzed very quickly. Computers also allow a greater
sense of anonymity for participants. Because surveys are theoretically easy to implement, it can
be deceptive as to the amount of detail and time that is required in order to properly carry out the
data collection.
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In addition to having advantages, the use of surveys may hold some disadvantages in the
research process. A few notable ones include the possibility of a low response rate, resulting in a
small sample size (Safdar et al., 2016). The response rate is of great concern due to the goal of
getting an accurate representation of the target population. A low response rate may lead to
nonresponse bias, which must be considered when statistical calculations are conducted (Sadfar
et al., 2016).
Concerns may also emerge if the target population does not have strong literacy skills.
Good reading comprehension is vital for accurate survey completion, because it is crucial for the
survey to correctly reflect the participant’s views. The target population may possibly be
inattentive or uncooperative with the survey instructions (Safdar et al., 2016). As for survey
responses from participants, their given responses may not be probed afterward for additional
detail.
The use of surveys with adolescents holds special points to consider. Some may question
if adolescents are capable of giving accurate self-report answers. A study by Fan et al. (2006)
classified the inaccurate responses of adolescent falsifiers as falling into two distinct categories.
They include “inaccurate responders” and “jokesters.” The “inaccurate responders” provide
wrong answers due to the participant’s carelessness or confusion (Fan et al., 2006). The
“jokesters” include those who intentionally provide false answers (Fan et al., 2006). The
researchers reported that while the falsifying effect may not significantly impact research
findings with large sample sizes, it remains a challenge for statistical accuracy to be established
in the study.
There are also concerns as to whether adolescents are reliable enough to accurately selfreport about their mood and mental status. Since concerns are already raised for those without
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disabilities, concerns of accurate self-reporting are even higher among those with cognitive
disabilities. This is definitely a concern among lupus patients due to the neuropsychiatric
involvement that some pediatric patients may experience.
Nolan (2016) describes the seeking of health information in surveys as an example of
self-reported health. It is a convenient manner of getting information due to the multiple
dimensions and layers of health which can be accessed (Kuhn, Rahman, and Menken, 2006).
Several decades ago, self-reported health was optimistically viewed as being a valid and reliable
tool for research. As time passed on, researchers have discovered various conceptual and
methodological challenges in studies involving youths and self-reported health. Adults’ selfreporting patterns have been studied for numerous years, and its study among adolescents has
become more frequent and more detailed than in previous years. Numerous studies have tried to
determine whether young children have the ability to assess their own health status (Riley, 2004).
Age and maturity have been factors in the ability to participate in studies involving such skills
(Riley, 2004).
Research involving self-reported surveys often accept proxy reports when the primary
participant is unavailable or somehow impacted in terms of age or disability. The conclusion
offered by Nolan (2016) stated that evidence for the use of both proxy and self-reports are
valuable. The authors found that proxy reports were slightly more robustly associated with the
amount of health information. Consequently, the authors recommended that researchers should
involve both proxy and self-report surveys in situations involving adolescent health information.
It is important to remember that the proxy and self-reports are not interchangeable, but they can
definitely complement one another and provide possible correlational evidence between the two
reports (Nolan, 2016).
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Nolan (2016) discovered in their study involving adolescent self-reporting that all
physical health indicators show an increased chance of being rated worse than the parent’s
ratings. The only exception to this pattern occurs during puberty. It was specifically found that
adolescent patients who have a long-term condition consistently produced “significantly higher
odds of rating worse” on the health-related survey (Nolan, 2016). The statistic which they
mentioned was that the pattern of “having a long-term health problem is associated with four
times the odds” compared to their comparable peers (Nolan, 2016). Gender differences emerged
as well with the parents of female adolescents less likely to state that their daughters have worse
health than their peers. This result was not found among male adolescents.
In a study conducted by Arciuli et al. (2019), school satisfaction was examined through
the interacting factors of gender and disability. The study included a sample size of 3,830
adolescents. Their results revealed that girls with disabilities “reported the lowest school
satisfaction” and the strongest mediating variable appears to be the “perceived lack of teacher
support” (Arciuli et al., 2019). Consequently, patients who have lupus are at high risk of having
low “school satisfaction” since lupus tends to impact females. Extra attention should be directed
to such students for the sake of disability care and their educational needs.
Jones et al. (2013) organized medical surveys/questionnaires into three categories. These
three categories include epidemiological surveys, surveys regarding attitudes toward a particular
intervention or service, and questionnaires tapping into the level of knowledge about a specific
issue or topic. Healthcare surveys are unique due to the potential benefits it may generate for
both healthcare providers and patients (Aday, 2006).
According to Lenhart (2013), efforts to conduct research on youth under the age of 18
years is limited due to the costs and complications which are involved. There are some
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challenges that are unique to minors between the ages of 12 and 17 years old. For example,
minors cannot consent to research without their parents’ approval. Consent varies by state but it
stems from the opinion that adolescents are not yet capable of making good decisions that are in
their best interest.
Contrasting opinion holds that the use of surveys among adolescents is appropriate,
because their cognitive functioning is developed enough to understand concepts of negations and
logic (de Leeuw, 2011). There has been debate over the developmental differentiation of
adolescents from children (Santelli et al., 2003). These legal complexities must be addressed due
to questions surrounding parental consent in research and the operational definition of a "minor".
However, the limitations of research must be bound by ethical practice, in addition to legal
compliance.
One example of such limitations involves statutes involving the Health Insurance
Portability and Accountability Act (HIPAA) and minors. The Center for Disease Control (CDC)
reported that only four states that have established specific laws relating specifically to
adolescents, instead of using the terminology of "children" or "minors" (Santelli et al., 2003).
Those states advocated that adolescents should be in a separate category due to the fact that this
developmental stage is more autonomous and mature than individuals categorized as “children”.
Numerous studies are employing self-reporting measures in a wide variety of disciplines in order
to gain information on children’s thoughts and feelings (Greco et al., 2016).
Proeschold-Bell categorizes test-takers into two general groups. She names these two
groups of participants as “optimizers” and “satisficers” (Global Health Institute, 2018). The
optimizers complete the survey with careful thought and dedicated motivation. The satisficers do
not put forth an equal amount of effort into taking the survey. Proeschold-Bell reported that:
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“You have to assume that everyone is going to be a satisficer, so you need to make all the steps
as easy as possible.” That is why Proeschold-Bell recommends that the survey design consist of
simple, concrete words (Global Health Institute, 2018). She also makes an interesting point that
items which are placed at the end of a survey are prone to the “satisficers” influence, while
optimizers appear to improve their accuracy as the survey progresses (Global Health Institute,
2018). The involvement of a neutral choice on the survey is dependent on which mindset will be
taking the survey.
The surveys in the present study will elicit demographic information and input regarding
the participant's current educational program and accommodations. The non-standardized
surveys (see Appendix A) will be tailored toward patients who are in middle or high school, or
parents of this pediatric population.
Item Development and Content Validation
Item development. Due to the passive approach to data collection in this study, one of
the specific goals in this effort was to include eye-catching designs in order to attract interest and
curiosity in the survey. By having such eye-catching designs in a hospital or clinic, patients and
their parents would be more likely to look at the survey. Nolan (2016) reported that adolescents
are more likely to take the survey if there is enough visual appeal.
Brevity is a key concern due to the possible joint pain which patients may experience
during the writing process and/or the possibility of overloading patients with paperwork.
Paperwork overload is possible for new patients, because they are usually asked to complete
numerous medical forms during the initial appointment. If the survey appears long, it would be
easy for them to ignore it. The survey must be brief and relevant enough to maintain prolonged
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attention for survey completion. Nolan (2016) recommends the use of multiple-choice responses,
because it facilitates brevity.
Because the surveys are anonymous, items requesting demographic information and
health-related data were included. For example, there is an item requesting the participant to list
his/her present medications. For example, chemotherapy was included as a factor within the
analysis due to its common use among pediatric patients. That medicinal strategy is common
during flare-ups of the illness (Castro-Santana, 2010).
The content for the surveys were extracted from various journal articles, with either an
educational or medical context, which focused on SLE. In these articles, authors penned various
accommodations which are recommended for individuals with this illness. The intent was to
include pertinent, research-based accommodations, but the appearance of brevity remained an
underlying factor during the survey construction.
Since there does not appear to be any studies relating to educational accommodations for
lupus, accommodations of conditions which are considered to be medically related to the
autoimmune family of illnesses were considered. Recommendations from a variety of medical
publications and the implemented pilot test confirmed the relevance of the survey's list of
accommodations for the school setting. The specific reasons to justify the inclusion of each
accommodation on the survey are as follows:
1. Preferential seating: The student may sit in the front to boost alertness. The student
may also sit in the back, for ease of exit to the bathroom or to the nurse's office.
2. Bathroom breaks as needed: Chemotherapy requires the patient to use the restroom
more frequently in order to protect the patient from kidney complications.
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3. Use of adaptive equipment for assignments: Arthritis is common in lupus, so writing
may be painful and challenging.
4. Allow extra time between classes: Arthritis may affect mobility or the student may
need to use the restroom.
5. Excuse from P.E. activities during active disease: Strenuous activity can aggravate
the illness and lead to excessive fatigue.
6. Morning tardiness at school can be excused: Patients may need more time due to
mobility issues and medication preparations.
7. Stretch as needed: Patients can relieve their arthritic joints through stretching.
8. Use of an elevator at school: Patients with severe mobility issues or severe fatigue
may need this type of support because the use of stairs may be challenging.
9. Transportation to/from school: Patients with severe mobility issues may need the
support if parents cannot transport the child.
10. Audio-record lectures/presentations: This would assist patients with frequent
absences or those with arthritis.
11. Allow verbal answers/reports: This would help patients with arthritic hands.
12. Permission to wear hat in class: This would alleviate embarrassment over hair loss.
13. Can see school nurse as needed: Patients can receive medical assistance with any
presenting symptoms at school. Patients may also rest in the nurse's office.
14. Extra time to complete assignments: This would help those with frequent absences
or hospitalizations. Those with arthritis can have more time to write/type.
15. Allow access to sunscreen at school: Since sunlight must be avoided, the reapplication of sunscreen is necessary.
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16. Extra set of textbooks for use at home: Fatigue and arthritis can make carrying a
heavy backpack a physical hardship.
17. Limit sun exposure: This will prevent a lupus flare-up.
18. Rest as needed: Severe fatigue is very common in patients with lupus.
19. Voice-typing software: This can help patients with arthritis.
20. Keep hand sanitizer on desk: Immunosupressed patients must avoid germs and
bacteria, which can complicate disease activity.
21. Sit in a comfortable style of desk: This can alleviate joint pain.
22. Provision of outlines/presentations: This is helpful for students with frequent
absences or hospitalizations.
23. Shortened school day: This is intended for those with severe fatigue.
24. Permission to wear gloves as needed: Blood circulation in fingers is impacted in
many patients with lupus (Raynaud's phenomenon).
An uncontrollable variable in the process of delivering established accommodations
involves the consistency of its implementation. Thus, the survey included an item to estimate the
teacher’s compliance with the patient’s accommodations. The level of compliance will help
determine if the patient truly received the established support.
Content validation. The initial English survey was examined by three school
psychologists, one teacher, one physician, and one professor. Feedback from the content
reviewers included the following recommendations:
1.

Use the term “student” instead of “patient.”

2. Include some type of notification to inform the participant that there is another
side to the survey.
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3. Add the term “guardian” instead of only using the term “parent.”
4. The title is deceptive, because it is not just a “school survey.”
5. Include “Other” in the gender options.
The bilingual version of the survey was constructed with the assistance of four fluent,
bilingual individuals who work or used to work in the school setting. The Spanish-speaking
translators included a veteran school secretary, a school psychologist, and two university
professors. Consequently, their English and Spanish skills are well-versed in terminology that is
appropriate to the school setting. Special attention was given to the range of Spanish fluency
through the inclusion of translators with mild fluency to those with strong bilingual fluency. The
intent was to make sure the surveys are understandable by all levels of Spanish-speaking
individuals.
For the sake of efficiency, the English survey was translated into Spanish through an
online interpretation program. After the resulting Spanish draft was produced, the bilingual
individuals read the draft and made corrections as needed. After two translators made corrections
to the survey, two other translators back-translated the translated draft to ensure accuracy and
appropriateness. In addition to the surveys, assent and consent forms for the hospitals were also
translated into Spanish.
The content validation process involved the distribution of the surveys to a small subset
of the target population in order to verify the validity of the items. The pilot test consisted of
patients with lupus and parents of children with lupus. Bilingual input was gained from a
bilingual parent of an adolescent with lupus. Additional insight regarding the survey items were
gained from an adult who had a personal diagnosis of lupus since her early childhood years.
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Pilot Study
A pilot study was conducted at the rheumatology clinic of Children’s Hospital of Orange
County. The surveys were completed by a convenience sample of five patients. The physician
gave the paper survey to patients within the target age range. The pilot survey consisted of 25
items which were the same as the final copy, except for one item.
The patients were able to complete the survey correctly as intended. No feedback for
improvement was given. One bilingual parent of a lupus patient and one adult lupus patient gave
verbal feedback that the survey was understandable. The adult lupus patient suggested that
physical education should be included in the survey, since that is physically strenuous for lupus
patients. Because of her feedback, the accommodation of “Excuse from activities during active
disease” was changed to “Excuse from P.E. activities during active disease.”
Because of the successful completion of the surveys by the patients and the parents, the
survey was then translated into Spanish. The Spanish translation was read by a fluent Spanish
speaker and a semi-fluent Spanish speaker. Both were able to understand the survey and its
intent. The pilot study showed that the protocol for the study was feasible.
Procedure and Participants
Procedure
The final draft of the survey consisted of 25 items (See Appendix K). The survey,
consent, and assent forms were approved by the Institutional Review Board of Chapman
University, Children’s Hospital of Orange County, Cottage Hospital, and University of
California Los Angeles' Mattel Hospital (Los Angeles, CA). The lead rheumatologists agreed to
participate in the study. These key rheumatologists included Dr. Andrew Shulman (CHOC), Dr.

66

Miriam Parsa (Cottage), and Dr. Deborah McCurdy (UCLA). The population of focus are the
pediatric rheumatology patients of the above-named physicians.
Surveys were constructed for pediatric rheumatology patients between 11 and 17 years of
age. Surveys, consent forms, and assent forms were provided in Spanish and English. Surveys
were placed near a locked box with a very thin slot for papers to be placed inside. It is similar to
a mailbox. Signs were not allowed in a few of the hospitals, which was why there were no signs
to alert patients of the surveys.
Once the surveys were completed by a patient or their parent/guardian, patients were
supposed to fold the survey and insert them into the mailbox-like box with a lock. As patients
and parents waited to see their physician, they could complete the survey during their wait. This
passive method of recruitment is reliant on the potentially excessive boredom which patients
may possibly experience during their wait to see the rheumatologist. The surveys were available
in all three clinics for a period of approximately 5 months.
Due to the lack of surveys involved with this type of investigation, the present survey was
designed based on general accommodations which lupus organizations and medical websites
have recommended. Rankings were used instead of simple multiple-choice selections, so that
more information can be gained regarding the differences between the choices. For example,
having an accommodation chosen as the top choice by numerous patients shows the relationship
between that top choice and other options. It is also helpful to see if there is a specific pattern in
the ranking, such as intervention A always proceeding intervention D or intervention B always
following intervention C. The surveys are limited to just English and Spanish translations.
The reason for providing sample accommodations for the patient to circle/underline is
due to the possible physical and neuropsychiatric issues in patients with lupus, especially for
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those who are taking high doses of steroids. By seeing some possibilities, it may help the patient
to recall their own accommodations more easily. As for content validation of the survey, the
survey was examined by three university professors and at least one rheumatologist.
Scoring simply involved counting the votes for each accommodation. The medications
which were listed was examined carefully to ensure their validity. For example, some
participants listed their vitamins in addition to their medications. The vitamins were not counted
toward the medication totals.
Participants
Participants in the present study were middle school or high school students who have
systemic lupus erythematosus. Their ages ranged from 11 to 18 years, with the mean age being
15.17 (SD=2.34). The participants’ grade levels ranged from 6th grade to 12th grade. The sample
consisted of 32 females, 3 males, and 1 identifying as “Other.”

Table 1
Age Levels of the Participants
-------------------------------------------------------------------------Age
n
%
-------------------------------------------------------------------------11
4
10.3
12
2
5.1
13
1
2.6
14
8
20.5
15
5
12.8
16
2
5.1
17
6
15.4
18
8
20.5
Missing
3
7.7
Total
39
100
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Table 2
Grade Levels of the Participants
-----------------------------------------------------------------------Grade
n
%
-----------------------------------------------------------------------6
4
10.3
7
1
2.6
8
2
5.1
9
5
12.8
10
6
15.4
11
5
12.8
12
11
28.2
Missing
5
12.8
Total
39
100
Table 3
Gender of the Participants
----------------------------------------------------------------------Gender
n
%
----------------------------------------------------------------------Males
3
7.7
Females
32
82.1
Other
1
2.6
Missing
3
7.7
-----------------------------------------------------------------------

These students were patients in one of the three participating lupus clinics (Children’s Hospital
of Orange County, Cottage, UCLA Mattel Hospital). The ethnic backgrounds of the participants
were primarily from minority groups, namely Hispanic, African-American, and Asian
backgrounds. The participant characteristics are representative of the typical lupus patient
population. The high number of female and ethnic minority patients are representative of typical
lupus patients.
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Table 4
Ethnicity of the Participants
------------------------------------------------------------------------Ethnicity
n
%
------------------------------------------------------------------------African-American
2
5.1
Hispanic
19
48.7
White
1
2.6
Asian
4
10.3
Other
2
5.1
Missing
10
25.6

All of the participating students were passing their classes, according to their grade point
average (GPA). The mean grade point average for this sample is 3.60 (SD=0.58). This number
appears to be rather high considering the various challenges which the students have in terms of
disease activity, medication side effects, and possible school attendance issues.
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Table 5
Grade Point Averages of the Participants
-------------------------------------------------------------------------Grade Point Average
n
%
-------------------------------------------------------------------------2.00
1
2.6
2.90
1
2.6
3.00
3
7.7
3.20
2
5.1
3.30
1
2.6
3.50
3
7.7
3.70
3
7.7
3.80
3
7.7
3.92
1
2.6
3.99
1
2.6
4.00
3
7.7
4.40
1
2.6
4.50
1
2.6
4.70
1
2.6
Missing
14
35.9

Since almost one-third of the patients were not taking corticosteroids, it is possible that
many of the patients in the present sample are in the remission phase of the lupus cycle. Being in
the remission phase equates with less severe symptoms of the illness. Many patients did not give
their corticosteroid dosages, but the ones who did were taking low to moderate doses. Twentyfive of the participants were ingesting corticosteroids and five of them were undergoing
chemotherapy.
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Table 6
Participants' Medication Details
-------------------------------------------------------------------------------Corticosteroid Intake
n
%
-------------------------------------------------------------------------------Yes
25
64.1
No
11
28.2
Missing
3
7.7
------------------------------------------------------------------------------Chemotherapy Intake
n
%
------------------------------------------------------------------------------Yes
5
12.8
No
31
79.5
Missing
3
7.7

The mean number of total medications that were being ingested was 2.6 (SD=1.83). That
means that their disease activity likely is under control enough to function adequately at school.
The total number of medications also shows that most of the participants were doing well
healthwise, since almost one-third of them were taking only one medication.

Table 7
Total Number of Medications Taken by Participants
------------------------------------------------------------------------------Total # of Medications
n
%
------------------------------------------------------------------------------None
2
5.1
1
12
30.8
2
4
10.3
3
7
17.9
4
4
10.3
5
3
7.7
6
2
5.1
7
1
2.6
Missing
4
10.3
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The following table provides information on the family’s income:

Table 8
Family Income of the Participants
--------------------------------------------------------------------------Family Income
n
%
--------------------------------------------------------------------------<$20,000
9
23.1
<$40,000
11
28.2
<$60,000
8
20.5
<$80,000
2
5.1
Above $80,000
4
10.3
Missing
5
12.8

The participants may also be parents/guardians of these students since the survey allows
its completion by either the parent/guardian or the student. Assent and consent forms were
provided for the patients and their parents/guardians to review prior to giving their informed
consent.
Chapter Summary
The present study required unique medical and educational considerations for the
different variables of the survey development process. The non-standardized survey consisted of
four sections with a total of 25 items. The four sections included a demographic section, a school
services inquiry, a school accommodations inquiry, and rankings of present and ideal
accommodations. The demographics section included specific questions about the student's
personal and medical background. The next section inquired about any educational support
which the student may have been receiving. The accommodations inquiry required the student to
identify all of the accommodations which were presently being provided to the student. The
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concluding section asked the participant to choose the best three accommodations which were
presently being provided to him/her. The final step in that section involved ranking the top three
ideal accommodations for students with SLE to have in order to earn a high school diploma.
The survey was then examined by a panel of four psychometric professionals, one
medical professional, and two lupus-acquainted individuals to ensure adequate content validity.
Four bilingual professionals were involved in producing a Spanish translation of the survey. A
pilot study was conducted at Children's Hospital of Orange County.
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Chapter 4: Results
The variables of presently given accommodations and ideal accommodations were
examined and compared for similarities or differences. Any possible correlation between
medications and grade point average were also examined. Descriptive statistics were used to
examine formalized plans and programs. The small sample size of 39 limits the use of extensive
statistical analysis due to its limited statistical power. There is a greater margin of error with a
small sample size. Consequently, a few statistical analyses will be offered, but the main results
cannot be tested for significance. Cell values involved very low numbers and there were
numerous ties involving those low numbers. A descriptive analysis will be offered through a
direct summary of the findings. The data were analyzed using a Pearson correlation coefficient
and a Spearman's Rho correlation coefficient.
A Pearson correlation coefficient was specifically used to examine the correlation
between participants’ grade point average and their total number of medications. The resulting
statistic was -.333 (p = .104). Thus, there was a moderate, inverse relationship where higher
number of medications ingested was associated with the lower grade point averages, although the
result was not statistically significant.
Due to the categorical variables involved, a Spearman's Rho was conducted in order to
examine the relationship between the students' present accommodations and ideal
accommodations. The results revealed a moderate, statistically significance relationship between
the second-place present accommodation and the second place ideal accommodation (r = .452, p
= .035). There were no other significant correlations. Because there are no studies examining
these variables, the results cannot be compared with past findings.
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Table 9
Spearman's Rho Correlation Coefficients

Accom 1

Accom 2

Accom 3

Ideal 1

Ideal 2

Ideal 3

Correl. Coeff.

.256

.304

.386

p Value

.216

.149

.063

Correl. Coeff.

.167

.452*

-.038

p Value

.447

.035

.867

Correl. Coeff.

-.226

-.290

-.084

p Value

.299

.191

.709

*p < .05, two-tailed

One-third of the students had 504 plans while slightly less than one quarter had
Individualized Education Plans (IEP’s). Thus, most of the students in the present sample had
some type of additional academic support in place at their schools.
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Table 10
Summary of Presently-Provided Services
-------------------------------------------------------------------------504 Plans
n
%
-------------------------------------------------------------------------Yes
13
33.3
No
15
38.5
Don't Know
8
20.5
Missing
3
7.7
------------------------------------------------------------------------IEP’s
n
%
------------------------------------------------------------------------Yes
9
23.1
No
24
61.5
Don't Know
2
5.1

The total number of accommodations also shows that to be true. Only one student out of 32 who
responded did not receive any accommodations.
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Table 11
Total Number of Formal and Informal Accommodations Provided to Participants
-----------------------------------------------------------------------------------------Total Accommodations
Number of Students
%
-----------------------------------------------------------------------------------------0
1
2.6
1
5
12.8
2
1
2.6
3
2
5.1
4
4
10.3
5
2
5.1
6
1
2.6
7
4
10.3
8
1
2.6
9
2
5.1
10
1
2.6
13
1
2.6
14
2
5.1
16
2
5.1
17
2
5.1
18
1
2.6
Missing
7
17.9
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Figure 1
Total Number of Accommodations Provided to Participants at School

An inquiry into teachers’ compliance rate with their students’ accommodations produced the
following results. The responses were too few to draw any formal conclusions.
Table 12
Teacher Compliance with Students’ Accommodations
---------------------------------------------------------------------------Compliance Percentage
n
%
---------------------------------------------------------------------------50%
1
2.6
70%
2
5.1
90%
3
7.7
100%
4
10.3

Based on the students’ survey responses, the accommodation that was consistently chosen most
frequently was “Extra time to complete assignments.” It was the top choice for the most
valuable accommodation which they were presently receiving for all three rankings (first choice,
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second choice, and third choice). It was also the top choice for the ideal accommodation for a
student with lupus (most ideal, second ideal, and third ideal choice).
Table 13
Participants' First Place Rankings of Present Accommodations
-----------------------------------------------------------------------------------------------------------First Choice of Present Accommodations
n
%
-----------------------------------------------------------------------------------------------------------2 (Bathroom breaks as needed)
4
10.3
3 (Use of adaptive equipment for assignments)
2
5.1
4 (Allow extra time between classes)
2
5.1
5 (Excuse from P.E. activity during active disease)
4
10.3
6 (Morning tardiness at school can be excused)
2
5.1
8 (Use of an elevator at school)
2
5.1
9 (Transportation to/from school)
1
2.6
13 (Can see school nurse as needed)
2
5.1
14 (Extra time to complete assignments)
8
20.5
16 (Extra set of textbooks for use at home)
1
2.6
18 (Rest as needed)
2
5.1
Missing
9
23.1
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Figure 2
Participants’ First Place Rankings of Present Accommodations

As for the rest of the accommodations which clustered at the top of the list of
accommodations which they were receiving, the participants voted for “Bathroom breaks as
needed”, “Excuse from P.E. activities during active disease”, “Can see school nurse as needed”,
and “Limit sun exposure.” Those five accommodations, including “Extra time to complete
assignments”, were voted as being most helpful out of the accommodations which they currently
had.
On the list of ideal accommodations, the cluster of most frequently chosen
accommodations after the top choice of “Extra time to complete assignments” included a wider
variety of choices. They included “Excuse from P.E. activities during active disease”, “Morning
tardiness at school can be excused”, “Bathroom breaks as needed”, “Extra set of textbooks for
use at home”, “Rest as needed”, and “Shortened school day.” Two individuals wrote in
accommodations of their own, which was having a “notetaker” in class. All of these
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accommodation choices can benefit students with SLE who are suffering from either mild to
severe disease activity.

Table 14
Participants' First Place Rankings of Ideal Accommodations
-----------------------------------------------------------------------------------------------------------First Choice of Ideal Accommodations
n
%
-----------------------------------------------------------------------------------------------------------4 (Allow extra time between classes)
1
2.6
5 (Excuse from P.E. activity during active disease)
3
7.7
6 (Morning tardiness at school can be excused)
3
7.7
8 (Use of an elevator at school)
1
2.6
9 (Transportation to/from school)
1
2.6
10 (Audio-record lectures/presentations)
1
2.6
13 (Can see school nurse as needed)
2
5.1
14 (Extra time to complete assignments)
9
23.1
15 (Allow access to sunscreen at school)
1
2.6
16 (Extra set of textbooks for use at home)
1
2.6
17 (Limit sun exposure)
1
2.6
18 (Rest as needed)
1
2.6
21 (Sit in a comfortable style of desk)
1
2.6
25 (Other)
2
5.1
Missing
11
28.2
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Figure 3
Participants’ First Place Rankings of Ideal Accommodations

The participants clearly made their choice with “Extra time to complete assignments”
being the most desired accommodation from their list of present accommodations and their list of
ideal accommodations. This accommodation does not directly benefit their physical well-being,
but instead benefits their academic functioning. Since the sample apparently consists of pediatric
patients on the milder end of the autoimmune spectrum, it is logical for physical well-being to
not be a top concern in their daily functioning. In order to maintain good grades, having the
extra time to complete assignments would compensate for time lost to medical appointments and
treatment.
Based on the presently-given accommodations, the top choices for second place resulted
in a three-way tie. They included “Bathroom breaks as needed”, “Excuse from P.E. activity
during active disease,” and “Extra time to complete assignments.” As for the third place choice,

83

“Extra time to complete assignments” took the lead, with seeing the school nurse being close
behind it.

Table 15
Participants' Second Place Rankings of Present Accommodations
-----------------------------------------------------------------------------------------------------------Second Choice of Present Accommodations
n
%
-----------------------------------------------------------------------------------------------------------2 (Bathroom breaks as needed)
4
10.3
5 (Excuse from P.E. activity during active disease)
4
10.3
7 (Stretch as needed)
1
2.6
8 (Use of an elevator at school)
1
2.6
9 (Transportation to/from school)
1
2.6
11 (Allow verbal answers/reports)
1
2.6
12 (Permission to wear hat in class)
2
5.1
13 (Can see school nurse as needed)
2
5.1
14 (Extra time to complete assignments)
4
10.3
15 (Allow access to sunscreen at school)
1
2.6
16 (Extra set of textbooks for use at home)
1
2.6
17 (Limit sun exposure)
1
2.6
18 (Rest as needed)
1
2.6
22 (Provision of outlines/presentations)
2
5.1
25 (Other)
1
2.6
Missing
12
30.8
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Figure 4
Participants’ Rankings of Second Place Present Accommodations

Table 16
Participants' Third Place Rankings of Present Accommodations
-----------------------------------------------------------------------------------------------------------Third Choice of Present Accommodations
n
%
-----------------------------------------------------------------------------------------------------------2 (Bathroom breaks as needed)
3
7.7
4 (Allow extra time between classes)
1
2.6
5 (Excuse from P.E. activity during active disease)
3
7.7
6 (Morning tardiness at school can be excused)
2
5.1
13 (Can see school nurse as needed)
4
10.3
14 (Extra time to complete assignments)
5
12.8
15 (Allow access to sunscreen at school)
1
2.6
16 (Extra set of textbooks for use at home)
1
2.6
17 (Limit sun exposure)
3
7.7
18 (Rest as needed)
2
5.1
20 (Keep hand sanitizer on desk)
1
2.6
23 (Shortened school day)
1
2.6
Missing
12
30.8

85

Figure 5
Participants’ Third Place Rankings of Present Accommodations
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Table 17
Participants' Second Place Rankings of Ideal Accommodations
-----------------------------------------------------------------------------------------------------------Second Choice of Ideal Accommodations
n
%
-----------------------------------------------------------------------------------------------------------2 (Bathroom breaks as needed)
3
7.7
4 (Allow extra time between classes)
1
2.6
5 (Excuse from P.E. activity during active disease)
2
5.1
6 (Morning tardiness at school can be excused)
2
5.1
7 (Stretch as needed)
1
2.6
9 (Transportation to/from school)
1
2.6
12 (Permission to wear hat in class)
1
2.6
14 (Extra time to complete assignments)
3
7.7
16 (Extra set of textbooks for use at home)
3
7.7
17 (Limit sun exposure)
1
2.6
18 (Rest as needed)
2
5.1
19 (Voice-typing software)
1
2.6
21 (Sit in a comfortable style of desk)
1
2.6
22 (Provision of outlines/presentations)
2
5.1
23 (Shortened school day)
2
5.1
25 (Other)
1
2.6
Missing
12
30.8
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Figure 6
Participants’ Second Place Rankings of Ideal Accommodations

Table 18
Participants' Third Place Rankings of Ideal Accommodations
-----------------------------------------------------------------------------------------------------------Third Choice of Ideal Accommodations
n
%
-----------------------------------------------------------------------------------------------------------1 Preferential Seating
1
2.6
2 (Bathroom breaks as needed)
2
5.1
4 (Allow extra time between classes)
1
2.6
5 (Excuse from P.E. activity during active disease)
1
2.6
6 (Morning tardiness at school can be excused)
1
2.6
7 (Stretch as needed)
2
5.1
11 (Allow verbal answers/reports)
1
2.6
13 (Can see school nurse as needed)
1
2.6
14 (Extra time to complete assignments)
4
10.3
17 (Limit sun exposure)
1
2.6
18 (Rest as needed)
5
12.8
23 (Shortened school day)
4
10.3
24 (Permission to wear gloves as needed)
1
2.6
25 (Other)
2
5.1
Missing
12
30.8
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Figure 7
Participants’ Third Place Rankings of Ideal Accommodations

Chapter Summary
The present findings demonstrate that most of the pediatric patients in this sample were
receiving some type of accommodation from their schools, whether it be formal or informal
support. The formal support consists of one-third of students having 504 plans and almost onequarter having individualized education plans. The general demographics of the small sample
appear to be representative of typical pediatric lupus patients, due to the predominance of the
female gender and the predominance of ethnic minority groups in the sample. All students,
except two, were able to achieve grade point averages above a 3.00.
An examination of the rankings revealed that one accommodation stood out from the rest.
It was consistently voted within the top three accommodations on both the list of present
accommodations and the list of ideal accommodations. That winning accommodation was “Extra
time on accommodations.” The highest-ranking cluster of accommodations on the list of present
89

accommodations besides the top accommodation included “Bathroom breaks as needed” and
“Excuse from P.E. activities” during active disease. The votes were more varied on the ideal list
of accommodations.
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Chapter 5: Discussion
The purpose of the present study was to examine the provision of educational
accommodations to students who have systemic lupus erythematosus. Data were collected
through a 25-item paper survey which were completed by 39 participants.
Overall, the grades of the participants appears to be rather high for a sample with health
issues which may affect school attendance and academic performance. It is possible that their
grades were good due to the implementation of appropriate accommodations. Another possible
reason for the good grades involves adult accountability. In addition to parents asking about their
academic performance, they also have a medical team (physicians, nurses, medical social
workers) who are regularly inquiring about their school functioning.
A different perspective for the high grade point average points to the possibility that most
of the participants were attending high school. High school students may be more inclined to
have higher grades due to possible plans of applying to colleges and universities. High school
students would be more motivated to perform at their best while middle school students lack
such immediate pressure. The additional issue of maturity may be an underlying factor as well.
Research Question 1a: What are the educational accommodations that a
participant is presently receiving?
Based on the 39 participants’ survey responses, every one of them had some type of
formal or informal accommodation in place at their school, except for one student. Only one
student out of the 39 participants did not receive any extra support. Approximately 56% of the
students did not have formally established accommodations, while 44% had formally authorized
accommodations through a 504 Plan or an IEP. Some students did not know whether or not they
had a 504 plan or an IEP.
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Research Question 1b: What are the student's favorite accommodations in rank
order out of the presently-received accommodations? The participants were asked to rank
their current accommodations (which were provided by their schools) according to their
helpfulness toward earning a high school diploma.
When asked to rank their given accommodations according to their effectiveness for
earning a high school diploma, the participants chose 1) Extra time to complete assignments 2)
Bathroom breaks as needed 3) Excuse from P.E. activity during active disease. Those second and
third choices were tied at four votes each, which fell distantly behind the leader with eight votes.
Research Question 2: What is the student's preferred or ideal accommodations in
rank order in terms of helpfulness toward earning a high school diploma?
When asked to choose the ideal accommodations for a student with SLE, the participants
picked 1) Extra time to complete assignments, 2) Morning tardiness at school can be excused, 3)
Excuse from P.E. activity during active disease. Those second and third choices were tied at
three votes and fell distantly behind the first choice with nine votes.
Research Question 3: Is there any correlation between participants' grade point
average and their total number of medications?
A Pearson correlation coefficient was calculated to see if there was any correlation
between participants’ grade point average and their total number of medications. The resulting
statistic was -.333, p=.104. Thus, this small sample does not appear to demonstrate a statistically
significant relationship between the variables of grade point average and total number of
medications. A larger sample size, with added statistical power, may possibly lead to a stronger
relationship.
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Research Question 4: What is the percentage of students who currently have a 504
Plan or an Individualized Education Program (IEP) in place?
In this sample of 39 participants, nine of them had IEP’s and 13 had 504 Plans. In terms
of percentages, 23.1% of the sample had IEP’s and 33.3% of the sample had 504 plans.
Research Question 5: How similar or dissimilar are the rank-ordered lists of given
accommodations and the ideal accommodations?
It appears that both lists of given accommodations and ideal accommodations share the
most frequently chosen accommodation, which is "Extra time to complete assignments". There
was more variation in responses on the list of ideal accommodations. There were also more
choices that may be difficult to obtain from a school, such as a "shortened school day", "extra set
of textbooks for use at home", and having a "notetaker."
Summary of the Findings
Overall, the results indicated that the majority of students who participated in the present
study received some type of accommodation to alleviate the challenges involved with systemic
lupus erythematosus. When the participating students were asked to rank their favorite three
given accommodations that would help to achieve a high school diploma, the highest ranking
accommodations included "Extra time to complete assignments, "Bathroom breaks as needed",
and "Excuse from P.E. activity during active disease." When the participating students were ask
to give three ideal accommodations that would help to achieve a high school diploma, their
highest chosen accommodations included "Extra time to complete assignments," "Morning
tardiness at school can be excused," and "Excuse from P.E. activity during active disease."
Based on this small sample, almost one-quarter of the students had an IEP, and one third of the
students had a 504 Plan.
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Study Strengths
The opening strength of the present study lies in the fact that this is the only examination
that has been conducted of the specific educational needs of secondary students with systemic
lupus erythematosus, according to the available literature. A key strength of the study involved
the participation of three hospitals. Having three hospitals increased the likelihood of a
reasonable sample size. In addition, it increased the likelihood of achieving a diverse range of
illness severity and diversity in ethnic and socioeconomic backgrounds. The wide spectrum of
illness severity can be observed through the medications which were listed. Some students were
prescribed small maintenance dosages of medication, while others were administered several
serious medications, such as chemotherapy. The demographic data results showed that a diverse
representation of individuals was achieved. Furthermore, it mirrored previous research data on
how SLE affects minorities at a significantly higher rate than Caucasians. It was also
advantageous to have a Spanish translation of the survey, considering that many of the survey
participants are ethnically Hispanic.
The content of the survey appears to be a strength, because each of the accommodations
on the survey was checked at least once in some manner. This demonstrates the validity of the
content, since the students chose the accommodation, either as a wish or as a present provision.
Consequently, the listed accommodations accurately reflected their needs in the educational
environment.
Study Limitations
The primary limitation in the present study is the small sample size which resulted from
the passive approach to data collection. The data collection period occurred over a 5-month
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timeframe, but the response rate remained low at all three hospitals. One of the reasons for this
phenomenon involved the age of the target population.
At the largest hospital, the lupus patients were more likely to be within the college-aged
range rather than in the secondary school range. It just so happened that the majority of patients
at that hospital were young adults who were attending college instead of high school. Thus, they
could not take the surve since the target population was middle or high school students.
The issue of age relates to the statistic regarding the length of time it takes to diagnose a
new patient with lupus. The median age for the symptoms of lupus to emerge is between 14 to 15
years old. As mentioned in the literature review, the timeframe from noticeable symptoms to an
actual diagnosis is around 6 months. By combining the statistics which were cited, the average
pediatric lupus diagnosis (14.6 years) added with the timeframe toward an actual diagnosis
would equal approximately 15 years of age. The diagnosis of younger children is more
challenging due to the cognitive and verbal skills which are needed in order to express
discomfort or problematic physical functioning. Because of that estimated statistic, the study
would probably have had more high school students than middle school students. That statistic
decreases the likelihood of participation by middle school students, which would further limit the
sample size.
Age is a factor affecting the outcome of this study for an additional reason. Due to the
present digital age of technology, it is possible that the rate of participation could have been
improved by using online surveys instead of paper surveys. Some may argue that the new
generation of adolescents in middle and high school would prefer online surveys over paper
surveys. Research-based evidence has not been solidly established yet regarding this issue of
preferences in survey participation.
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A major factor to consider involves the challenge of recruiting minority participants for
the study since SLE often affects minority communities. Minorities have long been
underrepresented in research (Diaz, 2012). George et al. (2014) reported that the level of mistrust
by minorities manifests differently so there must be culture-specific strategies to reach each
group. The word “research” can evoke feelings of fear as visual images of laboratories and
medical procedures come to mind. They may not be familiar with the possibility of other types of
research.
Language is the other barrier to participating in research. Even though the present study
has a Spanish version of the survey, SLE affects many other cultures. For example, systemic
lupus erythematosus frequently affects Asian countries. Yet, there were no bilingual versions of
the survey for those bilingual communities. These significant barriers of language and
unfamiliarity may impede research by limiting the sample size. All three hospitals in this study
have a significant variety of ethnic backgrounds, but the largest minority group among the three
hospitals are bilingual in Spanish.
The lack of diversity in the small sample can be observed through the high grade point
averages and mild form of SLE. The majority of the participants had grade point averages above
a 3.00. The majority of participants likely also had mild cases of lupus, based on the medications
and dosages which they revealed in their surveys. So, the typical participant appears to be a good
student who is only experiencing mild symptoms of the illness. The small sample of these types
of participants further limits the generalizability of this study’s findings.
Implications for Practice and Training
This study provides evidence that it is possible for students with lupus to achieve
academically in a manner that is comparable to their peers. However, they display enough needs
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and limitations to qualify for IEP's and 504 Plans. Teachers were sympathetic enough to provide
informal accommodations to students if they did not have a formally established set of
accommodations. It is possible that the patients' high grade point averages may be the result of
the implementation of the accommodations. If that truly is the case, then this study would
provide some evidence of the beneficial effects of providing accommodations to students with
lupus. It is important to remember the possibility that this self-selected sample may have a
confounding variable involving an association of high achievement and willingness to take the
survey. The high achievement may further relate to being high school-aged.
Participants in the present study chose their top three ideal accommodations as extra time
on assignments, being excused from P.E. activities during active disease, and forgiveness of
morning tardiness. Having extra time on the assignments would allow the students to use some
time for rest and medical appointments and the additional time can be dedicated to their
assignments. The accommodation of being excused from P.E. activities would shield students
from sun exposure and strenuous activities. Finally, the freedom to be tardy allows students
adequate time to take medications and put on sunscreen. While the top choice has an indirect
benefit to pediatric patients, the second and third choice are more closely linked with illness.
These accommodations do not demand much time or effort from teachers, which makes them
more likely to be implemented without complaint.
Since the list of ideal accommodations and the list of presently given accommodations
are almost identical, it shows that the participants are able to get what they want from their
schools. What they currently have is what they would like to have. This may be due to the
participants’ self-advocacy for these accommodations and/or the school’s sensitivity to the
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participants’ needs. Either way, self-advocacy for each student remains important in order to get
all of the ideal accommodations established through formal documentation.
Even though a direct causal relationship between certain school accommodations and
stable health cannot be established, the peace of mind which the students and their parents can
have in knowing they are supported at school is helpful for their psychological well-being, which
can indirectly boost their physical well-being. Since most of the accommodations which the
patients were receiving were listed on the survey, one practical implication for physicians is to
keep a copy of this survey so that they can formally request such accommodations for their
patients. It would be helpful for parents to also have a copy so that they can be aware of what
they may request on behalf of their child with lupus. School counselors and school psychologists
should also be acquainted with this list since they will encounter more patients with lupus during
their careers.
Implications for Future Research
The level of resilience displayed by the students with lupus inspires wonder as to how
they were able to achieve such good grades despite battling a life-threatening chronic illness.
Questions regarding factors which contribute to their resiliency would be good to answer, since it
may offer some helpful insight which may assist children with other forms of chronic illness.
Future research may also incorporate medical aspects into future studies, such as using
bloodwork to examine specific blood counts. The student's health can be correlated with schoolrelated accommodations in order to tease out which accommodation has the best direct effect on
their health. Researchers can use bloodwork to determine the effectiveness of specific school
placements as well, such as the patient's participation in the "Resource Specialist Program"
(RSP) or a special day class. A possible question could be "Would pediatric patients who are on
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chemotherapy exhibit less inflammation in the classroom or in the home/hospital program?"
Having the bloodwork numbers can more accurately confirm or deny the effectiveness of a
chosen variable. Since lupus patients are required to have regular bloodwork to examine their
physical condition, it would be beneficial to have them journal regularly about school and a
correlational study can be conducted on the relationship between bloodwork and school.
Research also should be conducted with college students (young and older adults)
regarding the accommodations they may be receiving. Given that college students with
disabilities often receive less support than younger students which may result in undue stress,
research is warranted on the types of accommodations that college students receive and perceive
to be useful.
The biggest hurdle to obtaining such answers involves the collaboration between school
psychologists and physicians. That type of partnership is necessary for future studies in pediatric
school psychology to be conducted. The research fusion of medicine and education would be
beneficial for students with medical conditions, so that their quality of life can be improved and
their resilience can be optimized.
Conclusion
Providing accommodations to students with disabilities is a legal and ethical approach to
support their educational endeavors. The present study examined the accommodations and
accommodation preferences of students with systemic lupus erythematosus in order to learn
which accommodations are most effective, according to their experience and perspectives. One
accommodation stood out from the rest, and that was having extended time to complete
assignments. Since this was a favorite accommodation from the lists of given accommodations
and ideal accommodations, it is recommended that this accommodation be considered when
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writing a 504 plan or IEP for a child with lupus. Although the sample size of the present study is
small and lacks statistical power, the high frequency of this accommodation choice caused it to
stand out from other accommodations.
Even though extra time on assignments was the leading choice among the rest of the
accommodations, it is important to remember that accommodations are a very personalized and
individualized form of academic support. Any established accommodation should focus on the
specific needs of the child in the school environment. The accommodation does not need to have
research backing for it to be attempted, because every child with lupus has unique medical and
educational needs. Increasing the public's awareness of such needs may offer direct or indirect
support to all students, with systemic lupus erythematosus or other chronic conditions, so they
may have the opportunity to achieve their goals.
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APPENDICES
Appendix A

IRB Approval from Children’s Hospital of Orange County



From: Shannon Tanaka <STanaka@choc.org>
Date: Thu, Jun 20, 2019 at 2:06 PM
Subject: RE: Email for Dr. Shulman
To: Seng <seng100@mail.chapman.edu>
Cc: Megan Bailey <mebailey@choc.org>

Hi MaryAnn,
That sounds great. Again, as long as zip code is removed from the surveys, it would not be
considered human subject research therefore would not require any additional review through our IRB.
Let me know if anything changes or if you or Dr. Shulman have any additional questions.
Best of luck with everything.
Thanks,
Shannon

Shannon Tanaka
Manager, Research Programs
Children’s Hospital of Orange County
Research Institute
1201 W. La Veta Avenue
Orange, CA 92868
Email: stanaka@choc.org
Cell: 949-292-3123
Office: 714-509-7534
Fax: 714-509-4318
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Appendix B
IRB Approval from UCLA’s Mattel Children’s Hospital


---------- Forwarded message --------From: Lillig, Paul <PLillig@research.ucla.edu>
Date: Tue, Jun 25, 2019 at 6:55 AM
Subject: UCLA IRB Review Not Required
To: Seng <seng100@mail.chapman.edu>

Thank you MaryAnn.

We have determined that UCLA IRB review is not required for your research
project titled “The Perceived Effectiveness of School-Based accommodation for
students with Systemic Lupus Erythemosus”.

Please consider my dated signature on the attached document the formal notice
of this determination.

Thank you,

Paul Lillig
NGIRB Administrator
310.206.2091
plillig@research.ucla.edu
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Appendix C
IRB Approval from Cottage Hospital

















128

Appendix D
IRB Approval from Chapman University

129

Appendix E

Content Validation Protocol
(If you are completing this form, please do NOT
complete the survey again during the actual study.)

Thank you for carefully examining this survey for the purpose of improvement. Please
feel free to write your edits and/or ideas directly on the attached survey. Please rate
the statements below and write any input which you may have. Thank you for your
participation and ideas!
(Awful) 5

4

3

2

1


(Perfect)


The purpose for the survey is valid.

__________

The directions on the survey are understandable.

__________

The wording of the items are clear to me.

__________

Response options to the questions were logical.

__________

The order of the items are appropriate.

__________

The list of possible accommodations are comprehensive.

__________

Items on the survey were not offensive.

__________

The length of the survey was reasonable.

__________

The accommodation(s) which should have been included in the accommodation list is/are:
_____________________________________________________________________________________
_____________________________________________________________________________________
Themes/Topics which should have been included are:
_____________________________________________________________________________________
_____________________________________________________________________________________
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Themes/Topics which should not have been included are:
_____________________________________________________________________________________
_____________________________________________________________________________________
Additional Ideas to improve the quality of the survey:
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Appendix F
PARENT INFORMED CONSENT TO PARTICIPATE IN
ANONYMOUS SURVEY RESEARCH
PLEASE read this consent form before choosing whether to allow your child’s
participation. Because the research involves an anonymous survey and does not include
any personally identifying information, your written permission will not be required. By
allowing your child to complete the survey you are providing permission to the researchers
to use the responses in our research. You may assist your child in completing the survey.
We thank you for your consideration.

IRB #:
The IRB will add this number when your application is approved.
Title of Study:
The Perceived Effectiveness of School-Based Accommodations for Students with
Autoimmune Conditions
Members of the Research Team
Lead Researcher: Randy Busse, Ph.D.
Student Researcher: MaryAnn Seng

Office: 714-997-6783
Cell Phone: 714-862-6290

Key Information
This is a request for your consent for your child to participate in a research study that
examines secondary students' accommodations at school. Only secondary students
(middle & high school) or parents of a secondary student with lupus may participate.
Please complete only one survey per family. You are not required to complete this
anonymous survey. Your medical care is not dependent upon the completion of this
survey. If you agree to allow your child to answer the survey questions, the task can be
completed in about 15 minutes. You may help your child to complete the survey. You or
your child may choose to skip any question/item. The level of risk is minimal. If you
encounter any problems with the survey, please contact the research contact person,
MaryAnn Seng at 714-487-4500. There is no compensation for participation. Please
keep this consent form for your records.
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Invitation
Parent(s) of Middle and High School Students: Please consider participating in this
study about school and students who have an autoimmune condition. The following
information will provide further detail about the study. Feel free to contact the
researcher at 714-487-4500 if you have any questions.
Why are you being asked to be in this research study?
The study focuses on middle and high school students who have an autoimmune
condition and their accommodations at school.

What is the reason for doing this research study?
The reason for the study is based on the fact that autoimmune conditions are most
often diagnosed during the adolescent years. Very few studies have focused on
pediatric autoimmune patients, particularly involving the topic of school
accommodations. Thus, an examination of school accommodations may help us better
understand pediatric patients' physical well-being and educational success.
What will be done during this research study?
In the clinic's waiting room, secondary school patients will be encouraged to take a
brief survey about their school programs and accommodations. The questions focus
on your child’s educational programs, current accommodations and preferred
accommodations. You may assist your child in the completion of the survey. The
survey is anonymous, therefore you will not be asked to provide any personally
identifying information about yourself or your child. You or your child may skip any
item if you do not wish to respond to it.

How will my information be used?
The anonymous survey responses will be used by the researchers in order to gather
information about school accommodations for children with autoimmune conditions.

What are the possible risks of being in this research study?
As with any study involving the collection of data, there is the possibility of breach of
confidentiality. Other risks include possible emotional and/or psychological distress
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because the surveys involve sensitive questions about your child’s medical condition
and treatment.

There are no known risks to you or your child for being in this research study.
What are the possible benefits to you or your child?
There are no benefits for participation in this study.

What are the possible benefits to other people?
Children with autoimmune conditions may benefit from the findings of this study,
which may provide schools with information regarding accommodations that may help
young patients to succeed in the educational environment.
What are the alternatives to being in this research study?
There are no alternatives to participation. You may choose not to participate.
.
What will participating in this research study cost you?
There is no cost to you to be in this research study.

Will you be compensated for being in this research study?
You will not be compensated for your participation in this research study.

What should you do if you have a problem during this research study?
Your welfare is the major concern of every member of the research team. If you have a
problem as a direct result of being in this study, you should immediately contact one of
the people listed at the beginning of this consent form.

How will information about you be protected?
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Reasonable steps will be taken to protect your privacy and the confidentiality of your
study data. Because the surveys are anonymous, your responses are unidentifiable.
The data will be stored electronically through a secure server and will only be seen by
the research team during the study and for 10 years after the study is complete.
The only people who will have access to your research records are the members of the
research team, the Institutional Review Board (IRB), and any other person, agency, or
sponsor as required by law. Information from this study may be published in scientific
journals or presented at scientific meetings but the data will be reported as group or
summarized data and your identity will be kept strictly confidential.
Please note that all Chapman University employees are required to report any known
or suspected abuse of children or minors to appropriate authorities.

What are your rights as a research subject?
You may ask any questions about this research and have those questions answered
before agreeing to participate in the study or during the study. For study related
questions, please contact the investigator listed at the beginning of this form. For
questions concerning your rights or complaints about the research, contact the
Chapman University Institutional Review Board at (714)628-2833 or
irb@chapman.edu.
What will happen if you decide not to be in this research study or decide to stop
participating once you start?
You can decide not to be in this research study, or you can stop being in this research
study (i.e., "withdraw") at any time before, during, or after the research begins for any
reason. Deciding not to be in this research study or deciding to withdraw will not
affect your relationship with your physician, the investigator or with Chapman
University. You will not lose any benefits to which you are entitled.

Documentation of informed consent
By allowing your child, with or without your help, to complete this anonymous survey
you are providing consent for participation. Please keep this form for your records.
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Appendix G
CHAPMAN UNIVERSITYASSENT TO PARTICIPATE IN RESEARCH
School-Based Accommodations for Students with Lupus
Participating in this study is totally voluntary. Please read about the study below. Feel free to ask
questions about anything that you do not understand before deciding if you want to be in the
study. A researcher listed below can answer your questions.
Principal Investigator: Randy T Busse, PhD Chapman University
Phone: 714-997-6783; email busse@chapman.edu
Contact Person: MaryAnn Seng
Phone: 714-487-4500; email seng100@mail.chapman.edu

Why am I asked to be in this study?
A research study is usually done to find a better way to treat people or to understand how
things work. You are asked to participate in this study because you are in middle school or high
school and you have lupus. It is important to understand lupus in the context of school since
you spend a lot of time in that setting.

What should I know about a research study?
You do not have to be in this study if you do not want to do so. It is up to you if you want to
participate. You can choose not to take part now and change your mind later if you want. Your
decision will not be held against you. You can ask all the questions you want before you decide.

Why is this research being done?
In this study, we want to find out more about how teens with lupus feel about the different ways
their schools help them.

How long is this study?
Your participation will only involve an anonymous survey that can be completed in 15 minutes.

Do I have to be involved in the study?
You do not have to be in the study. This study is not part of your healthcare. No one will be
mad at you if you don’t want to do this. If you don’t want to be in this study, you do not have to
complete the survey. If you want to be in this study, first ask your parent if it is ok and then
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complete the survey [your parent can help you with parts of the survey that you cannot answer].
You can say "yes" now and change your mind later. It is up to you to decide.

What happens if I say “Yes, I want to be in this research”?
If it is okay with you and you agree to join this study, you will be asked to complete an
anonymous survey [your parent can help] in your physician's waiting room. You will provide
some information about yourself like your age and gender, medications you might be taking,
and list your present school-based accommodations and your preferred accommodations.
Accommodations are those things the school does for you to help you because you have lupus.
After you complete the survey place it in the lock box in the waiting room under the sign that
asks you to participate. Do not put your name on the survey.

Is there any way being in this study could be bad for me?
You may feel uncomfortable with some of the questions, but it most likely will not cause any
pain or negative feelings. You may skip any question and you may stop any time.

What happens to the information collected for the research?
The information will be used to help us understand how to better help students who have lupus
in school. The surveys are anonymous, so your name or identity will not be available to anyone.

Will you get better if you are in the study?
No, the study will not benefit you or help you, but the information may help us help students
like you in the school setting.

Who can I talk to?
If you have any questions about the study or any problems to do with the study you can contact
MaryAnn Seng 714-487-4500.
If you have questions about the study but want to talk to someone else who is not a part of the
study, you can call the Chapman University Institutional Review Board (IRB) at (714)-628-2833.
Confidentiality: We have ethical obligations to contact individuals to help you if you should
threaten to harm yourself. If keeping information obtained in this study private would
immediately put you in danger, we will release that information to protect you.

Now that you know about the study, if you complete the survey you are giving
your permission to be part of the study. Thank You!!!
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Appendix H
Spanish Assent Form
ASENTIMIENTO PARA PARTICIPAR EN LA INVESTIGACIÓN
Adaptaciones escolares para estudiantes con Condiciones autoinmunes
Participar en este estudio es totalmente voluntario. Lea sobre el estudio a continuación.
No dude en hacer preguntas sobre cualquier cosa que no entienda antes de decidir si desea
participar en el estudio. Un investigador enumerado a continuación o su médico, la Dra. Miriam
Parsa, pueden responder sus preguntas.
Investigador principal: Randy T Busse, PhD Chapman University
Teléfono: 714-997-6783; correo electrónico busse@chapman.edu
Persona de contacto: MaryAnn Seng
Teléfono: 714-487-4500; correo electrónico seng100@mail.chapman.edu
¿Por qué me piden que participe en este estudio?
Por lo general, se realiza un estudio de investigación para encontrar maneras mejor de
tratar a las personas o comprender cómo funcionan las cosas. Se le pide que participe en este
estudio porque está en la escuela intermedia o secundaria y tiene una enfermedad autoinmune. Es
importante comprender las condiciones autoinmunes en el contexto de la escuela, ya que pasa
mucho tiempo en ese lugar.
¿Qué debo saber sobre un estudio de investigación?
No es necesario que participe en este estudio si no desea hacerlo. Depende de usted si
desea participar. Puede elegir no participar ahora y cambiar de opinión más adelante si lo desea.
Su decisión no se tomará en su contra. Puede hacer todas las preguntas que desee antes de
decidir.
¿Por qué se está haciendo esta investigación?
En este estudio, queremos saber más sobre cómo se sienten los adolescentes con
condiciones autoinmunes sobre las diferentes formas en que sus escuelas los ayudan.
¿Cuánto dura este estudio?
Su participación solo implicará una encuesta que tomará aproximadamente 15 minutos en
completarse.
¿Tengo que participar en el estudio?
No tienes que estar en el estudio. Este estudio no es parte de su atención médica. Nadie se
enojará contigo si no quieres hacer esto. Si no desea participar en este estudio, no tiene que
completar la encuesta. Si desea participar en este estudio, primero pregunte a sus padres si está
bien y luego complete la encuesta [sus padres pueden ayudarle con partes de la encuesta que no
puede responder]. Puede decir "sí" ahora y cambiar de opinión más tarde. Usted decide.
¿Qué sucede si digo "Sí, quiero participar en esta investigación"?
Si está de acuerdo con usted y acepta unirse a este estudio, se le pedirá que complete una
encuesta. Proporcionará información sobre usted, como su edad y sexo, los medicamentos que
podría estar tomando y enumerará sus acomodaciónes actuales basados en la escuela y sus las
adaptaciones preferidas. Las adaptaciones son aquellas cosas que la escuela hace para ayudarle
porque tiene una enfermedad autoimmune. No tendrá que proporcionar ninguna información que
pueda identificarlo como su nombre o código postal.
Después de completar la encuesta, doble el papel por la mitad y colóquelo en la caja
cerrada en el consultorio de su médico. No ponga su nombre en la encuesta.
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¿Hay alguna forma de participar en este estudio que pueda ser malo para mí?
Puede sentirse incómodo con algunas de las preguntas, pero lo más probable es que no le
cause ningún dolor o sentimientos negativos. Puede omitir cualquier pregunta y puede detenerse
en cualquier momento.
¿Qué sucede con la información recopilada para la investigación?
La información se usará para ayudarnos a comprender cómo ayudar mejor a los
estudiantes que tienen lupus en lugares escolares. Las encuestas son anónimas, por lo que su
nombre o identidad no estará disponible para nadie.
¿Mejorará si está en el estudio?
No, el estudio no lo beneficiará ni lo ayudará, pero la información puede ayudarnos a
ayudar a estudiantes como usted en lugares escolares.
¿Con quién puedo hablar?
Si tiene alguna pregunta sobre el estudio o cualquier problema relacionado con el estudio,
puede comunicarse con MaryAnn Seng 714-487-4500.
Confidencialidad: tenemos obligaciones éticas de contactar a las personas para ayudarlo
en caso de que amenace con lastimarse. Si mantener en privado la información obtenida en este
estudio lo pondría en peligro de inmediato, divulgaremos esa información para protegerlo.
Ahora que conoce el estudio, si completa la encuesta, está dando su permiso para ser
parte del estudio. Gracias.
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Appendix I
Spanish Consent Form
CONSENTIMIENTO INFORMADO DE LOS PADRES PARA PARTICIPAR EN LA
INVESTIGACIÓN DE ENCUESTA ANÓNIMA
La efectividad percibida de las adaptaciones escolares para estudiantes con enfermedades
autoinmunes
Investigador principal: Randy Busse, Ph.D., Universidad Chapman
Teléfono: 714-997-6783; correo electrónico busse@chapman.edu
Estudiante Investigador: MaryAnn Seng, Universidad Chapman
Teléfono: 714-487-4500; correo electrónico seng100@mail.chapman.edu
Lea este formulario de consentimiento antes de elegir si desea permitir la participación de
su hijo/a. Debido a que la investigación involucra una encuesta anónima y no incluye ninguna
información de identificación personal, no se requerirá su firma por escrito. Al permitir que su
hijo complete la encuesta, está dando permiso a los investigadores para usar las respuestas en
nuestra investigación. Usted puede ayudarle a su hijo/a a completar la encuesta. Le agradecemos
por su consideración.

Información clave
Esta es una solicitud de su consentimiento para que su hijo/a participe en un estudio de
investigación que examina las adaptaciones para los estudiantes en la escuela secundaria. Solo
pueden participar estudiantes de secundaria (escuela secundaria y escuela intermedia), o padres
de estudiantes de secundaria, con lupus. Por favor complete solo una encuesta por familia. Esta
encuesta anónima, no necesita.escribir sa nomb su participacion. Su atención médica no depende
de la finalización de esta encuesta. Si acepta permitir que su hijo responda las preguntas de la
encuesta, la solicitud se puede completar en aproximadamente 15 minutos. Usted puede ayudar a
su hijo/a a completar la encuesta. Usted o su hijo/a pueden optar por omitir cualquier pregunta /
artículo. El nivel de riesgo es mínimo. Si tiene algún problema con la encuesta, comuníquese con
la persona de contacto de la investigación, MaryAnn Seng, al 714-487-4500 o con su médico, la
Dra. Miriam Parsa. No hay compensación por la participación. Guarde este formulario de
consentimiento en sus registros.
Invitación
Padres de estudiantes de secundaria y escuela intermedia: considere participar en este
estudio sobre la escuela y los estudiantes que tienen una enfermedad autoinmune. La
información que sigue proporcionará más detalles sobre el estudio. No dude en comunicarse con
el investigador al 714-487-4500 si tiene alguna pregunta.

1

¿Por qué se le pide que participe en este estudio de investigación?
El estudio se enfoca en estudiantes de secundaria y escuela intermedia que tienen una
condición autoimmune y reciben acomodaciones en la escuela.
¿Cuál es la razón para hacer este estudio de investigación?
La razón del estudio se basa en el hecho de que las afecciones autoinmunes se
diagnostican con mayor frecuencia durante los años de la adolescencia. Muy pocos estudios se
han centrado en pacientes autoinmunes pediátricos, en particular sobre el tema de servicios en la
escuela. Por lo tanto, un examen de las adaptaciones escolares puede ayudarnos a comprender
mejor el bienestar físico y el éxito educativo de los pacientes pediátricos.
¿Qué se hará durante este estudio de investigación?
En la sala de espera de la clínica, se alentará a los pacientes de la escuela secundaria
contester a una breve encuesta sobre sus programas y adaptaciones escolares. Las preguntas se
centran en los programas educativos de su hijo, las adaptaciones actuales y las adaptaciones
preferidas. Puede ayudar a su hijo a completar la encuesta. La encuesta es anónima, por lo tanto,
no se le pedirá que proporcione información de identificación personal sobre usted o de su hijo/a.
Usted o su hijo/a pueden omitir cualquier elemento si no desean responderlo.
¿Cómo se usará mi información?
Los investigadores utilizarán las respuestas anónimas de la encuesta para reunir
información sobre lugares escolares para niños con afecciones autoinmunes.
¿Cuáles son los posibles riesgos de participar en este estudio de investigación?
Al igual que con cualquier estudio que involucre la colección de datos, existe la
posibilidad de violación de confidencialidad. Otros riesgos incluyen posibles trastornos
emocionales y / o psicológicos porque las encuestas involucran preguntas delicadas sobre la
condición médica y el tratamiento de su hijo/a.

No hay riesgos conocidos para usted o su hijo/a por participar en este estudio de
investigación.
¿Cuáles son los posibles beneficios para usted o su hijo?
No hay beneficios por participar en este estudio.

¿Cuáles son los posibles beneficios para otras personas?
Los niños con afecciones autoinmunes pueden beneficiarse de los resultados de este
estudio, que puede proporcionar a las escuelas información sobre las adaptaciones que pueden
ayudar a los pacientes jóvenes a tener éxito en el entorno educativo.
¿Cuáles son las alternativas a estar en este estudio de investigación?
Puedes elegir no participar.
¿Cuánto le costará participar en este estudio de investigación?
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No tiene ningún costo participar en este estudio de investigación.

¿Serás compensado por estar en este estudio de investigación?
No será compensado por su participación en este estudio de investigación.

¿Qué debe hacer si tiene un problema durante este estudio de investigación?
Su bienestar es la principal preocupación de cada miembro del equipo de investigación.
Si tiene un problema como resultado directo de participar en este estudio, debe comunicarse de
inmediato con una de las personas enumeradas al comienzo de este formulario de
consentimiento.
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Appendix J
Spanish Survey
 ENCUESTA ESCOLAR ANONIMA 
Complete esta encuesta si es padre de un estudiante / o si es un paciente que se encuentra actualmente en la
escuela intermedia (secundaria) o preparatoria. Por favor entregue solo una encuesta por familia. Al completar
esta encuesta, le está dando permiso al investigador para incluir sus respuestas en el estudio. Por favor imprima sus
respuestas claramente. NO ponga su nombre en la encuesta. Una vez que haya respondido a cada elemento en
nombre del paciente, coloque la encuesta en el recuadro bloqueado marcado "Encuestas completadas". ¡Muchas
gracias por su tiempo y participación!

Edad del estudiante: _______ Grado Escolar: _______ G.P.A. (Promedio de Calificaciones): ______
Origen étnico del estudiante: __________________________________________________________

Género: M F Otro

¿Cuál es el ingreso familiar total antes de impuestos en 2018? (Circule uno)
0- $20,000

$20,001- $40,000 $40,001- $60,000 $60,001-$ 80,000 $80,001+

Prefiero no

contestar Diagnóstico actual del estudiante:
___________________________________________________________________________________________________________________
¿Está el estudiante tomando esteroides?

Si

No

Nombre de esteroide: ___________________________________________________

MG total por día: _________________

Medicamentos actuales del estudiante (y dosis):
______________________________________________________________________________________________________________________
¿Está el estudiante actualmente en quimioterapia (IV o pastillas)?:

Sí

No

Frecuencia de la quimioterapia: ______________________________________________________________________

¿Tiene el estudiante un Plan 504 en la escuela?

Sí

No

No se

¿Tiene el estudiante un Programa de Educación Individualizado (IEP)?

Si

No

No se

Si se ha implementado un IEP, verifique cada servicio que el paciente recibe actualmente:
__ Programa de especialistas en recursos

__ Terapia ocupacional

Otro: ______________________

__ Clase de educaion especial

__ Terapia física

____________________________

__ Consejeria

__ Orientación y movilidad

____________________________

__Educación física adaptativa

__Servicios de habla / lenguaje

____________________________

En general, mis maestros siguen los arreglos especiales, como se delinea en mi Plan 504 o IEP, a una tasa
estimada de:
(Deje esto en blanco si no tiene acomodaciones establecidas)
0%

10%

20%

30%

40%

50%

60%
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Por favor verifique todos las acomodaciones especiales que su escuela ha proporcionado durante el presente
año escolar:

___1. Asientos preferenciales

___13. Puede ver a la enfermera de la escuela según sea

___2. Descanso para el baño según sea necesario

necesario

___3. Uso de equipo adaptativo para tareas

___14. Tiempo adicional para completar

___4. Permitir tiempo extra entre clases

___15. Permitir el acceso al protector solar en la escuela

___5. Excusa de actividades durante enfermedad activa

___16. Colección extra de libros para usar en casa

___6. Tardanzas de la mañana en la escuela pueden ser

___17. Limitar la exposición al sol
___18. Descansar según sea necesario

justificadas
___7. Estirarse según sea necesario

___19. Software de escritura de voz

___8. Uso de un ascensor/elevador en la escuela

___20. Mantener desinfectante de manos en el escritorio

___9. Transporte a / desde la escuela

___21. Sentarse en un escritorio con estilo cómodo

___10. Audio-grabar conferencias / presentaciones

___22. Provisión de resúmenes / presentaciones

___11. Permitir respuestas/reportes verbales

___23. Día escolar acortado según sea necesario

___12. Permiso para usar gorro/sombrero en clase

___24. Permiso de usar guantes según sea necesario

Otro:_______________________________________________________________________________________________________________________
______________________________________________________________________________________________________________


De la lista numerada anterior, ¿cuáles 3 acomodaciones especiales son más útiles? (Por favor escriba el número
que corresponde a sus elecciones.)
Primera opción: _________ Segunda elección: _________ Tercera Elección: _________
¿Qué 3 arreglos especiales serían ideales para su condición? [Se pueden elegir entre las opciones anteriores, ya
sea que estén marcadas o no, y / o puede escribir otros arreglos especiales.]
Primera opción: ____________________________________________________________________________________________________
Segunda opción: ___________________________________________________________________________________________________
Tercera opción: _____________________________________________________________________________________________________

Esta encuesta fue completada por [circule una]:
Paciente

Padre/Guardián del Paciente

Los Dos (Paciente y Padre/ Guardián)
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Appendix K
 ANONYMOUS SCHOOL SURVEY



Please complete this survey if you are a middle-school or high-school student. Your parent/guardian may help you
complete the survey or they can complete it for you. Please turn in only one survey per family. By completing this
survey, you are giving the researcher permission to include your answers in the study. Please print your answers
clearly. DO NOT put your name on the survey. After you have answered each item, please place the survey in the
locked box marked "Completed Surveys". Thank you very much for your time and participation!


Student’s Age: _______
Grade: _______ G.P.A.: ________
Gender (circle): Male Female Other
Student’s Ethnic Background: ______________________________________________________________________
What is the family’s total household income before taxes in 2018?
0-$20,000

$20,001-$40,000

$40,001-$60,000

$60,001-$80, 000

Above $80,000

Student’s Current Diagnosis:
_____________________________________________________________________________________
Is the student taking steroids?:

Yes

No

Steroid Name: _______________________________________ Total MG per day: ____________________________
Student’s Other Medications (and dosage):
_____________________________________________________________________________________
_____________________________________________________________________________________
Is the student currently on chemotherapy (IV or pills)?: Yes

No

Frequency of chemotherapy:______________


Does the student have a 504 Plan at school?

Yes

No

Does the student have an Individualized Education Program (IEP)?

Yes

Don't know
No

Don't know

If an IEP is in place, please check each service that the student currently is receiving:
__Resource Specialist Program
__Counseling
__Occupational Therapy
__Orientation & Mobility

__Special Day Class
__Adaptive Physical Education
__Physical Therapy
__Speech/Language Services

Other:__________________
_______________________
_______________________
_______________________

In general, my teachers follow the accommodations, as outlined in my 504 Plan or IEP, at an estimated rate of:
(Leave this blank if you do not have established accommodations)
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145

70%

80%

90%

100%

[please complete other side]
Please check every accommodation which your school has provided during the present school year:
___1. Preferential Seating

___13. Can see school nurse as needed

___2. Bathroom breaks as needed

___14. Extra time to complete assignments

___3. Use of adaptive equipment for assignments

___15. Allow access to sunscreen at school

___4. Allow extra time between classes

___16. Extra set of textbooks for use at home

___5. Excuse from P.E. activities during active disease

___17. Limit sun exposure

___6. Morning tardiness at school can be excused

___18. Rest as needed

___7. Stretch as needed

___19. Voice-typing software

___8. Use of an elevator at school

___20. Keep hand sanitizer on desk

___9. Transportation to/from school

___21. Sit in a comfortable style of desk

___10. Audio-record lectures/presentations

___22. Provision of outlines/presentations

___11. Allow verbal answers/reports

___23. Shortened school day

___12. Permission to wear hat in class

___24. Permission to wear gloves as needed

Other: __________________________________________________________________________________________



From the numbered list above, which 3 accommodations are most helpful? (Please write the number which represents your
choices.)
First Choice: _________
Second Choice: _________
Third Choice: _________
Which 3 accommodations would be ideal for your condition? [These may be chosen from the options above, whether
checked or not, and/or you may write in other accommodations.]
First Choice: _____________________________________________________________________________________
Second Choice: ___________________________________________________________________________________
Third Choice: ____________________________________________________________________________________


This survey was completed by [circle one]:
Student

Student’s Parent/Guardian

Both (Student and Parent/Guardian)
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Glossary of Terms
Anti-Ifnar: A substance/drug that blocks interferon-alpha's receptor
Anti-Nuclear Antibody: an antibody that targets and binds to regular proteins within a cell’s
nucleus; A significant amount of ANA’s may signal autoimmune disease
Aseptic meningitis: Inflammation of the tissues covering the brain and spinal cord
Autoantibody: An antibody that mistakenly identifies a “self protein” as being a foreign entity
Central Nervous System: Consists of the brain and spinal cord, which acts as a command center
to control other bodily systems
Corticosteroid: A steroid hormone that is produced by the adrenal cortex or their synthetic
equivalents; Various types produce different effects (such as alleviating inflammation)
Cytopenia: Occurs when one or more of the blood cell counts are lower than normal; There are
different types (e.g. Anemia is a type of cytopenia involving red blood cells, Leukopenia is a
type involving white blood cells)
Cytotoxic: Producing a destructive or toxic effect on cells
Cutaneous: Involving the skin
Cytokine: A general term for hormone-like proteins which are released by various cells types to
regulate immune response and cell communication
Epidemiology: The branch of medicine which focuses on the cause, incidence, distribution, and
control of disease in a population
Hematology: The branch of medicine that focuses on the diagnosis and treatment of diseases of
the blood and blood-forming tissues
Hemoglobin: A complex protein in red blood cells which carries oxygen via iron molecules; The
main role is to transport oxygen from the lungs to body tissue
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IFNAR (Interferon-Alpha): A small protein cytokine that acts like an alarm by triggering extra
immune activity when it binds with numerous receptors in different tissues
Immunosuppression: suppression of the immune system's response
Incidence: The rate or risk of contracting a new disease during a particular timeframe
Ischemic Stroke: One of the three main types of strokes that occurs when an artery in the brain
is blocked
Monoclonal antibody: A copy of a laboratory-produced antibody/parent cell which can be
designed to bind to a specific substance
Morbidity: The frequency or number of individuals who have a particular disease
Mortality: The rate or risk of death in a population
Myasthenia gravis: An autoimmune condition where the body attacks its own tissues,
particularly the connection between the nerve and the muscle
Nephrology: The study of kidney function and disease
Nephritis: Inflammation of the kidneys
Pathogenesis: The biological origination and development of a disease
Phenotype: The observable and measurable characteristics or an organism that is a physical
expression of the genes
Platelet: Colorless, disk-shaped cell fragments in the blood that are involved in blood clotting
Polychlorinated biphenyls (PCB's): A group of compounds used in the manufacture of plastics
and fluids used to coat metal, concrete, and wood; Manufacture of PCB's was stopped in 1977
due to its toxicity to human health and the environment
Prevalence: The proportion of the population who has a disease during a particular timeframe
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Psychoneuroimmunology: The study of how the brain, the nervous system, and the immune
system impact each other
Pulsing: The administration of a high dose of corticosteroids for a few days and tapering it down
or dropping it back to the low dose prior to the pulsing period
Rheumatology: The study of rheumatic conditions, such as arthritis, gout, tendinitis, and lupus
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